{
  "regulations" : [ {
    "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
    "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27 ],
    "type" : "Negative_regulation",
    "polarity" : false,
    "controller_indices" : [ 6, 7 ],
    "controlled_indices" : [ 23, 24, 25, 26, 27 ],
    "trigger_indices" : [ 10, 11 ],
    "rule_name" : "Negative_regulation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
    "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 ],
    "type" : "Negative_regulation",
    "polarity" : false,
    "controller_indices" : [ 6, 7 ],
    "controlled_indices" : [ 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 ],
    "trigger_indices" : [ 10, 11 ],
    "rule_name" : "Negative_regulation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
    "event_indices" : [ 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27 ],
    "type" : "Positive_regulation",
    "polarity" : true,
    "controller_indices" : [ 23, 24, 25, 26, 27 ],
    "controlled_indices" : [ 11, 12, 13, 14, 15 ],
    "trigger_indices" : [ 22, 23 ],
    "rule_name" : "Positive_regulation_syntax_3_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
    "event_indices" : [ 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 ],
    "type" : "Positive_regulation",
    "polarity" : true,
    "controller_indices" : [ 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 ],
    "controlled_indices" : [ 11, 12, 13, 14, 15 ],
    "trigger_indices" : [ 22, 23 ],
    "rule_name" : "Positive_regulation_syntax_3_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
    "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27 ],
    "type" : "Negative_regulation",
    "polarity" : false,
    "controller_indices" : [ 6, 7 ],
    "controlled_indices" : [ 11, 12, 13, 14, 15 ],
    "trigger_indices" : [ 10, 11 ],
    "rule_name" : "Negative_regulation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
    "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 ],
    "type" : "Negative_regulation",
    "polarity" : false,
    "controller_indices" : [ 6, 7 ],
    "controlled_indices" : [ 11, 12, 13, 14, 15 ],
    "trigger_indices" : [ 10, 11 ],
    "rule_name" : "Negative_regulation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
    "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27 ],
    "type" : "Negative_regulation",
    "polarity" : false,
    "controller_indices" : [ 23, 24, 25, 26, 27 ],
    "controlled_indices" : [ 11, 12, 13, 14, 15 ],
    "trigger_indices" : [ 22, 23 ],
    "rule_name" : "Positive_regulation_syntax_3_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
    "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 ],
    "type" : "Negative_regulation",
    "polarity" : false,
    "controller_indices" : [ 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37 ],
    "controlled_indices" : [ 11, 12, 13, 14, 15 ],
    "trigger_indices" : [ 22, 23 ],
    "rule_name" : "Positive_regulation_syntax_3_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Metformin", "and", "combination", "treatment", "modulate", "signaling", "molecules", "MAPK", "and", "mTOR", "." ],
    "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 0, 1 ],
    "controlled_indices" : [ 7, 8 ],
    "trigger_indices" : [ 4, 5 ],
    "rule_name" : "Positive_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Metformin", "and", "combination", "treatment", "modulate", "signaling", "molecules", "MAPK", "and", "mTOR", "." ],
    "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 0, 1 ],
    "controlled_indices" : [ 9, 10 ],
    "trigger_indices" : [ 4, 5 ],
    "rule_name" : "Positive_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Metformin", "alone", "and", "the", "metformin-vemurafenib", "combination", "treatment", "significantly", "decrease", "cell", "viability", "in", "BRAFV600E", "positive", "papillary", "and", "anaplastic", "thyroid", "cancer", "cells", "." ],
    "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 0, 1 ],
    "controlled_indices" : [ 9, 10, 11 ],
    "trigger_indices" : [ 8, 9 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "event_indices" : [ 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 3, 4 ],
    "controlled_indices" : [ 13, 14 ],
    "trigger_indices" : [ 7, 8 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 0, 1 ],
    "controlled_indices" : [ 8, 9, 10, 11, 12 ],
    "trigger_indices" : [ 7, 8 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 0, 1 ],
    "controlled_indices" : [ 16, 17 ],
    "trigger_indices" : [ 7, 8 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 0, 1 ],
    "controlled_indices" : [ 13, 14 ],
    "trigger_indices" : [ 7, 8 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "event_indices" : [ 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 3, 4 ],
    "controlled_indices" : [ 19, 20 ],
    "trigger_indices" : [ 7, 8 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 6, 7 ],
    "controlled_indices" : [ 16, 17 ],
    "trigger_indices" : [ 7, 8 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "event_indices" : [ 6, 7, 8, 9, 10, 11, 12 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 6, 7 ],
    "controlled_indices" : [ 8, 9, 10, 11, 12 ],
    "trigger_indices" : [ 7, 8 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 6, 7 ],
    "controlled_indices" : [ 19, 20 ],
    "trigger_indices" : [ 7, 8 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "event_indices" : [ 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 3, 4 ],
    "controlled_indices" : [ 16, 17 ],
    "trigger_indices" : [ 7, 8 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "event_indices" : [ 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 3, 4 ],
    "controlled_indices" : [ 8, 9, 10, 11, 12 ],
    "trigger_indices" : [ 7, 8 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "event_indices" : [ 6, 7, 8, 9, 10, 11, 12, 13, 14 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 6, 7 ],
    "controlled_indices" : [ 13, 14 ],
    "trigger_indices" : [ 7, 8 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Combination", "of", "vemurafenib", "and", "metformin", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "both", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "8505c", "anaplastic", "thyroid", "cancer", "cells", "." ],
    "event_indices" : [ 4, 5, 6, 7, 8, 9, 10, 11 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 4, 5 ],
    "controlled_indices" : [ 10, 11 ],
    "trigger_indices" : [ 9, 10 ],
    "rule_name" : "Positive_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Combination", "of", "vemurafenib", "and", "metformin", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "both", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "8505c", "anaplastic", "thyroid", "cancer", "cells", "." ],
    "event_indices" : [ 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 2, 3 ],
    "controlled_indices" : [ 10, 11 ],
    "trigger_indices" : [ 9, 10 ],
    "rule_name" : "Positive_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "The", "profound", "interaction", "of", "vemurafenib", "and", "rapamycin", "seen", "in", "BCPAP", "cells", "alone", "reflects", "cell", "specific", "sensitivity", "based", "on", "the", "wiring", "pattern", "of", "BRAFV600E", "mediated", "signal", "transduction", "." ],
    "event_indices" : [ 22, 23, 24, 25, 26 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 22, 23 ],
    "controlled_indices" : [ 24, 25, 26 ],
    "trigger_indices" : [ 23, 24 ],
    "rule_name" : "Positive_early_activation",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Combination", "of", "vemurafenib", "and", "metformin", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "both", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "8505c", "anaplastic", "thyroid", "cancer", "cells", "." ],
    "event_indices" : [ 4, 5, 6, 7, 8 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 4, 5 ],
    "controlled_indices" : [ 6, 7, 8 ],
    "trigger_indices" : [ 5, 6 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Combination", "of", "vemurafenib", "and", "metformin", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "both", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "8505c", "anaplastic", "thyroid", "cancer", "cells", "." ],
    "event_indices" : [ 2, 3, 4, 5, 6, 7, 8 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 2, 3 ],
    "controlled_indices" : [ 6, 7, 8 ],
    "trigger_indices" : [ 5, 6 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "This", "is", "an", "especially", "appealing", "combination", "because", "of", "the", "widespread", "use", "and", "low", "side", "effects", "of", "metformin", "seen", "in", "patients", "treated", "for", "diabetes", "mellitus", "type", "2.The", "second", "inhibitor", ",", "rapamycin", ",", "directly", "inhibits", "mTOR", "complex", "1", "." ],
    "event_indices" : [ 29, 30, 31, 32, 33, 34 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 29, 30 ],
    "controlled_indices" : [ 33, 34 ],
    "trigger_indices" : [ 32, 33 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Vemurafenib", "binds", "selectively", "to", "the", "active", "site", "of", "BRAFV600E", "protein", ",", "which", "differs", "in", "conformation", "from", "wild-type", "BRAF", ",", "and", "inhibits", "downstream", "MAPK", "signaling", "[", "7", "]", "." ],
    "event_indices" : [ 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 8, 9, 10 ],
    "controlled_indices" : [ 22, 23, 24 ],
    "trigger_indices" : [ 20, 21 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Metformin", "caused", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "BCPAP", "and", "BHP10-3SC", "papillary", "thyroid", "cells", "and", "inhibited", "BHP10-3SC", "tumor", "growth", "in", "nude", "mice", "." ],
    "event_indices" : [ 0, 1, 2, 3, 4, 5 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 0, 1 ],
    "controlled_indices" : [ 3, 4, 5 ],
    "trigger_indices" : [ 1, 2 ],
    "rule_name" : "Positive_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Both", "vemurafenib", "and", "metformin", "appear", "to", "have", "anti-cancer", "effects", "in", "thyroid", "cancer", ",", "and", "it", "is", "possible", "that", "adjuvant", "metformin", "therapy", "would", "not", "significantly", "increase", "toxicity", "in", "vemurafenib", "treated", "patients", "due", "to", "its", "high", "safety", "profile", "." ],
    "event_indices" : [ 19, 20, 21, 22, 23, 24, 25, 26, 27, 28 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 19, 20 ],
    "controlled_indices" : [ 27, 28 ],
    "trigger_indices" : [ 24, 25 ],
    "rule_name" : "Positive_activation_syntax_7_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Studies", "involving", "metastatic", "melanoma", "patients", "established", "that", "vemurafenib", "caused", "tumor", "regression", "and", "significantly", "reduced", "risk", "of", "death", "compared", "to", "standard", "dacarbazine", "treatment", ",", "although", "patients", "often", "developed", "resistance", "and", "disease", "progression", "resumed", "after", "6-8", "months", "[", "29", ",", "30", "]", "." ],
    "event_indices" : [ 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 7, 8 ],
    "controlled_indices" : [ 16, 17 ],
    "trigger_indices" : [ 13, 14 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Resistant", "BCPAP", "cells", "in", "this", "assay", "showed", "little", "variability", "in", "apoptosis", ",", "indicating", "that", "although", "combination", "treatment", "with", "metformin", "and", "vemurafenib", "inhibits", "growth", "of", "these", "cells", "(", "Figure", "1C", ")", ",", "it", "does", "not", "cause", "overt", "apoptosis", "that", "can", "be", "detected", "by", "the", "TUNEL", "assay", "[", "28", "]", "(", "Figure", "2A", ",", "2B", ")", "." ],
    "event_indices" : [ 31, 32, 33, 34, 35, 36, 37 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 31, 32 ],
    "controlled_indices" : [ 36, 37 ],
    "trigger_indices" : [ 34, 35 ],
    "rule_name" : "Positive_activation_syntax_1_verb, pronominalMatch",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Metformin", "caused", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "BCPAP", "and", "BHP10-3SC", "papillary", "thyroid", "cells", "and", "inhibited", "BHP10-3SC", "tumor", "growth", "in", "nude", "mice", "." ],
    "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 0, 1 ],
    "controlled_indices" : [ 7, 8 ],
    "trigger_indices" : [ 1, 2 ],
    "rule_name" : "Positive_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Metformin", "caused", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "BCPAP", "and", "BHP10-3SC", "papillary", "thyroid", "cells", "and", "inhibited", "BHP10-3SC", "tumor", "growth", "in", "nude", "mice", "." ],
    "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 0, 1 ],
    "controlled_indices" : [ 13, 14 ],
    "trigger_indices" : [ 1, 2 ],
    "rule_name" : "Positive_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 0, 1 ],
    "controlled_indices" : [ 19, 20 ],
    "trigger_indices" : [ 7, 8 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "The", "two", "mTOR", "inhibitors", "we", "chose", "are", "both", "clinically", "available", "with", "known", "pharmacokinetics", "and", "with", "somewhat", "differing", "mechanisms", "of", "action.Metformin", "transiently", "inhibits", "the", "respiratory", "chain", "complex", "1", "in", "mitochondria", "and", "this", "leads", "to", "an", "increase", "in", "ratio", "of", "AMP", "to", "ATP", ",", "thereby", "triggering", "activation", "of", "AMP", "activated", "protein", "kinase", "(", "AMPK", ")", ":", "the", "latter", "subsequently", "leads", "to", "mTOR", "inhibition", "[", "39-42", "]", "." ],
    "event_indices" : [ 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 30, 31 ],
    "controlled_indices" : [ 46, 47, 48 ],
    "trigger_indices" : [ 43, 44 ],
    "rule_name" : "Positive_activation_syntax_1_verb, pronominalMatch",
    "rule" : null
  }, {
    "sentence_tokens" : [ "While", "these", "studies", "collectively", "point", "out", "the", "therapeutic", "potential", "for", "vemurafenib", ",", "as", "a", "single", "targeted", "therapy", "it", "will", "likely", "not", "be", "able", "to", "prevent", "drug", "resistance", "and", "disease", "progression", "in", "the", "long", "term", "." ],
    "event_indices" : [ 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 17, 18 ],
    "controlled_indices" : [ 25, 26, 27 ],
    "trigger_indices" : [ 24, 25 ],
    "rule_name" : "Negative_activation_syntax_1_verb, pronominalMatch",
    "rule" : null
  }, {
    "sentence_tokens" : [ "While", "these", "studies", "collectively", "point", "out", "the", "therapeutic", "potential", "for", "vemurafenib", ",", "as", "a", "single", "targeted", "therapy", "it", "will", "likely", "not", "be", "able", "to", "prevent", "drug", "resistance", "and", "disease", "progression", "in", "the", "long", "term", "." ],
    "event_indices" : [ 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 17, 18 ],
    "controlled_indices" : [ 28, 29, 30 ],
    "trigger_indices" : [ 24, 25 ],
    "rule_name" : "Negative_activation_syntax_1_verb, pronominalMatch",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 0, 1 ],
    "controlled_indices" : [ 8, 9, 10, 11, 12 ],
    "trigger_indices" : [ 2, 3 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 0, 1 ],
    "controlled_indices" : [ 16, 17 ],
    "trigger_indices" : [ 2, 3 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 0, 1 ],
    "controlled_indices" : [ 13, 14 ],
    "trigger_indices" : [ 2, 3 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "The", "two", "mTOR", "inhibitors", "we", "chose", "are", "both", "clinically", "available", "with", "known", "pharmacokinetics", "and", "with", "somewhat", "differing", "mechanisms", "of", "action.Metformin", "transiently", "inhibits", "the", "respiratory", "chain", "complex", "1", "in", "mitochondria", "and", "this", "leads", "to", "an", "increase", "in", "ratio", "of", "AMP", "to", "ATP", ",", "thereby", "triggering", "activation", "of", "AMP", "activated", "protein", "kinase", "(", "AMPK", ")", ":", "the", "latter", "subsequently", "leads", "to", "mTOR", "inhibition", "[", "39-42", "]", "." ],
    "event_indices" : [ 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 30, 31 ],
    "controlled_indices" : [ 40, 41 ],
    "trigger_indices" : [ 31, 32 ],
    "rule_name" : "Positive_activation_syntax_7_verb, pronominalMatch",
    "rule" : null
  }, {
    "sentence_tokens" : [ "The", "two", "mTOR", "inhibitors", "we", "chose", "are", "both", "clinically", "available", "with", "known", "pharmacokinetics", "and", "with", "somewhat", "differing", "mechanisms", "of", "action.Metformin", "transiently", "inhibits", "the", "respiratory", "chain", "complex", "1", "in", "mitochondria", "and", "this", "leads", "to", "an", "increase", "in", "ratio", "of", "AMP", "to", "ATP", ",", "thereby", "triggering", "activation", "of", "AMP", "activated", "protein", "kinase", "(", "AMPK", ")", ":", "the", "latter", "subsequently", "leads", "to", "mTOR", "inhibition", "[", "39-42", "]", "." ],
    "event_indices" : [ 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 30, 31 ],
    "controlled_indices" : [ 46, 47, 48 ],
    "trigger_indices" : [ 31, 32 ],
    "rule_name" : "Positive_activation_syntax_1_verb, pronominalMatch",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Studies", "involving", "metastatic", "melanoma", "patients", "established", "that", "vemurafenib", "caused", "tumor", "regression", "and", "significantly", "reduced", "risk", "of", "death", "compared", "to", "standard", "dacarbazine", "treatment", ",", "although", "patients", "often", "developed", "resistance", "and", "disease", "progression", "resumed", "after", "6-8", "months", "[", "29", ",", "30", "]", "." ],
    "event_indices" : [ 7, 8, 9, 10 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 7, 8 ],
    "controlled_indices" : [ 9, 10 ],
    "trigger_indices" : [ 8, 9 ],
    "rule_name" : "Positive_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Metformin", "and", "combination", "treatment", "modulate", "signaling", "molecules", "MAPK", "and", "mTOR", "." ],
    "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 0, 1 ],
    "controlled_indices" : [ 7, 8 ],
    "trigger_indices" : [ 5, 6 ],
    "rule_name" : "Positive_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Metformin", "and", "combination", "treatment", "modulate", "signaling", "molecules", "MAPK", "and", "mTOR", "." ],
    "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 0, 1 ],
    "controlled_indices" : [ 9, 10 ],
    "trigger_indices" : [ 5, 6 ],
    "rule_name" : "Positive_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Sorafenib", "and", "lenvatinib", "both", "inhibit", "several", "protein", "kinases", "including", "vascular", "endothelial", "growth", "factor", "receptor", "(", "VEGFR", ")", "and", "platelet", "derived", "growth", "factor", "receptor", "(", "PDGFR", ")", "." ],
    "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 0, 1 ],
    "controlled_indices" : [ 9, 10, 11, 12, 13 ],
    "trigger_indices" : [ 4, 5 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Sorafenib", "and", "lenvatinib", "both", "inhibit", "several", "protein", "kinases", "including", "vascular", "endothelial", "growth", "factor", "receptor", "(", "VEGFR", ")", "and", "platelet", "derived", "growth", "factor", "receptor", "(", "PDGFR", ")", "." ],
    "event_indices" : [ 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 2, 3 ],
    "controlled_indices" : [ 9, 10, 11, 12, 13, 14 ],
    "trigger_indices" : [ 4, 5 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Sorafenib", "and", "lenvatinib", "both", "inhibit", "several", "protein", "kinases", "including", "vascular", "endothelial", "growth", "factor", "receptor", "(", "VEGFR", ")", "and", "platelet", "derived", "growth", "factor", "receptor", "(", "PDGFR", ")", "." ],
    "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 0, 1 ],
    "controlled_indices" : [ 9, 10, 11, 12, 13, 14 ],
    "trigger_indices" : [ 4, 5 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Sorafenib", "and", "lenvatinib", "both", "inhibit", "several", "protein", "kinases", "including", "vascular", "endothelial", "growth", "factor", "receptor", "(", "VEGFR", ")", "and", "platelet", "derived", "growth", "factor", "receptor", "(", "PDGFR", ")", "." ],
    "event_indices" : [ 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 2, 3 ],
    "controlled_indices" : [ 9, 10, 11, 12, 13 ],
    "trigger_indices" : [ 4, 5 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "The", "rapamycin", ":", "FKBP12", "complex", "inhibits", "the", "signal", "transduction", "ability", "of", "mTOR", ",", "preventing", "activation", "of", "multiple", "targets", "required", "for", "progression", "through", "cell", "cycle", "and", "resulting", "in", "G1", "phase", "arrest", "." ],
    "event_indices" : [ 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 3, 4 ],
    "controlled_indices" : [ 11, 12 ],
    "trigger_indices" : [ 5, 6 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "The", "rapamycin", ":", "FKBP12", "complex", "inhibits", "the", "signal", "transduction", "ability", "of", "mTOR", ",", "preventing", "activation", "of", "multiple", "targets", "required", "for", "progression", "through", "cell", "cycle", "and", "resulting", "in", "G1", "phase", "arrest", "." ],
    "event_indices" : [ 3, 4, 5, 6, 7, 8, 9 ],
    "type" : "Negative_activation",
    "polarity" : false,
    "controller_indices" : [ 3, 4 ],
    "controlled_indices" : [ 7, 8, 9 ],
    "trigger_indices" : [ 5, 6 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "The", "two", "mTOR", "inhibitors", "we", "chose", "are", "both", "clinically", "available", "with", "known", "pharmacokinetics", "and", "with", "somewhat", "differing", "mechanisms", "of", "action.Metformin", "transiently", "inhibits", "the", "respiratory", "chain", "complex", "1", "in", "mitochondria", "and", "this", "leads", "to", "an", "increase", "in", "ratio", "of", "AMP", "to", "ATP", ",", "thereby", "triggering", "activation", "of", "AMP", "activated", "protein", "kinase", "(", "AMPK", ")", ":", "the", "latter", "subsequently", "leads", "to", "mTOR", "inhibition", "[", "39-42", "]", "." ],
    "event_indices" : [ 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 30, 31 ],
    "controlled_indices" : [ 40, 41 ],
    "trigger_indices" : [ 31, 32, 33 ],
    "rule_name" : "Positive_activation_nested_syntax_2_verb, pronominalMatch",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Metformin", "caused", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "BCPAP", "and", "BHP10-3SC", "papillary", "thyroid", "cells", "and", "inhibited", "BHP10-3SC", "tumor", "growth", "in", "nude", "mice", "." ],
    "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 0, 1 ],
    "controlled_indices" : [ 18, 19 ],
    "trigger_indices" : [ 16, 17 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "event_indices" : [ 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 ],
    "type" : "Positive_activation",
    "polarity" : true,
    "controller_indices" : [ 0, 1 ],
    "controlled_indices" : [ 19, 20 ],
    "trigger_indices" : [ 2, 3 ],
    "rule_name" : "Negative_activation_syntax_1_verb",
    "rule" : null
  } ],
  "hardInstances" : [ {
    "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
    "entities_indices" : [ [ 14, 15 ], [ 17, 18, 19, 20 ], [ 36, 37 ] ]
  }, {
    "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
    "entities_indices" : [ [ 14, 15 ], [ 17, 18, 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
    "entities_indices" : [ [ 6, 7 ], [ 17, 18, 19, 20 ], [ 36, 37 ] ]
  }, {
    "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
    "entities_indices" : [ [ 6, 7 ], [ 17, 18, 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
    "entities_indices" : [ [ 17, 18, 19, 20 ], [ 26, 27 ], [ 36, 37 ] ]
  }, {
    "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
    "entities_indices" : [ [ 17, 18, 19, 20 ], [ 26, 27 ], [ 36, 37 ] ]
  }, {
    "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
    "entities_indices" : [ [ 6, 7 ], [ 17, 18, 19, 20 ], [ 36, 37 ] ]
  }, {
    "sentence_tokens" : [ "In", "terms", "of", "signaling", "molecules", ",", "metformin", "also", "appeared", "to", "inhibit", "expression", "of", "total", "mTOR", "within", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "increased", "expression", "of", "total", "mTOR", "in", "8505c", "cells", ",", "regardless", "of", "the", "presence", "of", "vemurafenib", "." ],
    "entities_indices" : [ [ 6, 7 ], [ 17, 18, 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "Metformin", "and", "combination", "treatment", "modulate", "signaling", "molecules", "MAPK", "and", "mTOR", "." ],
    "entities_indices" : [ [ 9, 10 ] ]
  }, {
    "sentence_tokens" : [ "Metformin", "and", "combination", "treatment", "modulate", "signaling", "molecules", "MAPK", "and", "mTOR", "." ],
    "entities_indices" : [ [ 7, 8 ] ]
  }, {
    "sentence_tokens" : [ "Metformin", "alone", "and", "the", "metformin-vemurafenib", "combination", "treatment", "significantly", "decrease", "cell", "viability", "in", "BRAFV600E", "positive", "papillary", "and", "anaplastic", "thyroid", "cancer", "cells", "." ],
    "entities_indices" : [ [ 16, 17, 18, 19 ] ]
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 6, 7 ], [ 8, 9, 10, 11, 12 ], [ 16, 17 ], [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 6, 7 ], [ 13, 14 ], [ 16, 17 ], [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 6, 7 ], [ 8, 9, 10, 11, 12 ], [ 13, 14 ], [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 6, 7 ], [ 8, 9, 10, 11, 12 ], [ 16, 17 ], [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 6, 7 ], [ 8, 9, 10, 11, 12 ], [ 13, 14 ], [ 16, 17 ] ]
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 3, 4 ], [ 8, 9, 10, 11, 12 ], [ 13, 14 ], [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 3, 4 ], [ 13, 14 ], [ 16, 17 ], [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 3, 4 ], [ 8, 9, 10, 11, 12 ], [ 13, 14 ], [ 16, 17 ] ]
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 6, 7 ], [ 8, 9, 10, 11, 12 ], [ 13, 14 ], [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 6, 7 ], [ 13, 14 ], [ 16, 17 ], [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 3, 4 ], [ 8, 9, 10, 11, 12 ], [ 16, 17 ], [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "Combination", "of", "vemurafenib", "and", "metformin", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "both", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "8505c", "anaplastic", "thyroid", "cancer", "cells", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 6, 7, 8 ], [ 14, 15, 16, 17 ], [ 20, 21, 22, 23 ] ]
  }, {
    "sentence_tokens" : [ "Combination", "of", "vemurafenib", "and", "metformin", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "both", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "8505c", "anaplastic", "thyroid", "cancer", "cells", "." ],
    "entities_indices" : [ [ 4, 5 ], [ 6, 7, 8 ], [ 14, 15, 16, 17 ], [ 20, 21, 22, 23 ] ]
  }, {
    "sentence_tokens" : [ "The", "profound", "interaction", "of", "vemurafenib", "and", "rapamycin", "seen", "in", "BCPAP", "cells", "alone", "reflects", "cell", "specific", "sensitivity", "based", "on", "the", "wiring", "pattern", "of", "BRAFV600E", "mediated", "signal", "transduction", "." ],
    "entities_indices" : [ [ 4, 5 ], [ 6, 7 ] ]
  }, {
    "sentence_tokens" : [ "Combination", "of", "vemurafenib", "and", "metformin", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "both", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "8505c", "anaplastic", "thyroid", "cancer", "cells", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 10, 11 ], [ 14, 15, 16, 17 ], [ 20, 21, 22, 23 ] ]
  }, {
    "sentence_tokens" : [ "Combination", "of", "vemurafenib", "and", "metformin", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "both", "BCPAP", "papillary", "thyroid", "cancer", "cells", "and", "8505c", "anaplastic", "thyroid", "cancer", "cells", "." ],
    "entities_indices" : [ [ 4, 5 ], [ 10, 11 ], [ 14, 15, 16, 17 ], [ 20, 21, 22, 23 ] ]
  }, {
    "sentence_tokens" : [ "This", "is", "an", "especially", "appealing", "combination", "because", "of", "the", "widespread", "use", "and", "low", "side", "effects", "of", "metformin", "seen", "in", "patients", "treated", "for", "diabetes", "mellitus", "type", "2.The", "second", "inhibitor", ",", "rapamycin", ",", "directly", "inhibits", "mTOR", "complex", "1", "." ],
    "entities_indices" : [ [ 16, 17 ], [ 22, 23, 24 ], [ 24, 25 ] ]
  }, {
    "sentence_tokens" : [ "Vemurafenib", "binds", "selectively", "to", "the", "active", "site", "of", "BRAFV600E", "protein", ",", "which", "differs", "in", "conformation", "from", "wild-type", "BRAF", ",", "and", "inhibits", "downstream", "MAPK", "signaling", "[", "7", "]", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 17, 18 ] ]
  }, {
    "sentence_tokens" : [ "Metformin", "caused", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "BCPAP", "and", "BHP10-3SC", "papillary", "thyroid", "cells", "and", "inhibited", "BHP10-3SC", "tumor", "growth", "in", "nude", "mice", "." ],
    "entities_indices" : [ [ 7, 8 ], [ 13, 14 ], [ 18, 19 ] ]
  }, {
    "sentence_tokens" : [ "Both", "vemurafenib", "and", "metformin", "appear", "to", "have", "anti-cancer", "effects", "in", "thyroid", "cancer", ",", "and", "it", "is", "possible", "that", "adjuvant", "metformin", "therapy", "would", "not", "significantly", "increase", "toxicity", "in", "vemurafenib", "treated", "patients", "due", "to", "its", "high", "safety", "profile", "." ],
    "entities_indices" : [ [ 1, 2 ], [ 3, 4 ] ]
  }, {
    "sentence_tokens" : [ "Studies", "involving", "metastatic", "melanoma", "patients", "established", "that", "vemurafenib", "caused", "tumor", "regression", "and", "significantly", "reduced", "risk", "of", "death", "compared", "to", "standard", "dacarbazine", "treatment", ",", "although", "patients", "often", "developed", "resistance", "and", "disease", "progression", "resumed", "after", "6-8", "months", "[", "29", ",", "30", "]", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 9, 10 ], [ 20, 21 ], [ 29, 30, 31 ] ]
  }, {
    "sentence_tokens" : [ "Resistant", "BCPAP", "cells", "in", "this", "assay", "showed", "little", "variability", "in", "apoptosis", ",", "indicating", "that", "although", "combination", "treatment", "with", "metformin", "and", "vemurafenib", "inhibits", "growth", "of", "these", "cells", "(", "Figure", "1C", ")", ",", "it", "does", "not", "cause", "overt", "apoptosis", "that", "can", "be", "detected", "by", "the", "TUNEL", "assay", "[", "28", "]", "(", "Figure", "2A", ",", "2B", ")", "." ],
    "entities_indices" : [ [ 10, 11 ], [ 18, 19 ], [ 20, 21 ] ]
  }, {
    "sentence_tokens" : [ "Metformin", "caused", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "BCPAP", "and", "BHP10-3SC", "papillary", "thyroid", "cells", "and", "inhibited", "BHP10-3SC", "tumor", "growth", "in", "nude", "mice", "." ],
    "entities_indices" : [ [ 3, 4, 5 ], [ 13, 14 ], [ 18, 19 ] ]
  }, {
    "sentence_tokens" : [ "Metformin", "caused", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "BCPAP", "and", "BHP10-3SC", "papillary", "thyroid", "cells", "and", "inhibited", "BHP10-3SC", "tumor", "growth", "in", "nude", "mice", "." ],
    "entities_indices" : [ [ 3, 4, 5 ], [ 7, 8 ], [ 18, 19 ] ]
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 6, 7 ], [ 8, 9, 10, 11, 12 ], [ 13, 14 ], [ 16, 17 ] ]
  }, {
    "sentence_tokens" : [ "The", "two", "mTOR", "inhibitors", "we", "chose", "are", "both", "clinically", "available", "with", "known", "pharmacokinetics", "and", "with", "somewhat", "differing", "mechanisms", "of", "action.Metformin", "transiently", "inhibits", "the", "respiratory", "chain", "complex", "1", "in", "mitochondria", "and", "this", "leads", "to", "an", "increase", "in", "ratio", "of", "AMP", "to", "ATP", ",", "thereby", "triggering", "activation", "of", "AMP", "activated", "protein", "kinase", "(", "AMPK", ")", ":", "the", "latter", "subsequently", "leads", "to", "mTOR", "inhibition", "[", "39-42", "]", "." ],
    "entities_indices" : [ [ 2, 3, 4 ], [ 19, 20 ], [ 38, 39 ], [ 40, 41 ], [ 51, 52 ], [ 59, 60 ] ]
  }, {
    "sentence_tokens" : [ "While", "these", "studies", "collectively", "point", "out", "the", "therapeutic", "potential", "for", "vemurafenib", ",", "as", "a", "single", "targeted", "therapy", "it", "will", "likely", "not", "be", "able", "to", "prevent", "drug", "resistance", "and", "disease", "progression", "in", "the", "long", "term", "." ],
    "entities_indices" : [ [ 10, 11 ], [ 28, 29, 30 ] ]
  }, {
    "sentence_tokens" : [ "While", "these", "studies", "collectively", "point", "out", "the", "therapeutic", "potential", "for", "vemurafenib", ",", "as", "a", "single", "targeted", "therapy", "it", "will", "likely", "not", "be", "able", "to", "prevent", "drug", "resistance", "and", "disease", "progression", "in", "the", "long", "term", "." ],
    "entities_indices" : [ [ 10, 11 ], [ 25, 26, 27 ] ]
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 6, 7 ], [ 13, 14 ], [ 16, 17 ], [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 6, 7 ], [ 8, 9, 10, 11, 12 ], [ 13, 14 ], [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 6, 7 ], [ 8, 9, 10, 11, 12 ], [ 16, 17 ], [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "The", "two", "mTOR", "inhibitors", "we", "chose", "are", "both", "clinically", "available", "with", "known", "pharmacokinetics", "and", "with", "somewhat", "differing", "mechanisms", "of", "action.Metformin", "transiently", "inhibits", "the", "respiratory", "chain", "complex", "1", "in", "mitochondria", "and", "this", "leads", "to", "an", "increase", "in", "ratio", "of", "AMP", "to", "ATP", ",", "thereby", "triggering", "activation", "of", "AMP", "activated", "protein", "kinase", "(", "AMPK", ")", ":", "the", "latter", "subsequently", "leads", "to", "mTOR", "inhibition", "[", "39-42", "]", "." ],
    "entities_indices" : [ [ 2, 3, 4 ], [ 19, 20 ], [ 38, 39 ], [ 46, 47, 48 ], [ 51, 52 ], [ 59, 60 ] ]
  }, {
    "sentence_tokens" : [ "The", "two", "mTOR", "inhibitors", "we", "chose", "are", "both", "clinically", "available", "with", "known", "pharmacokinetics", "and", "with", "somewhat", "differing", "mechanisms", "of", "action.Metformin", "transiently", "inhibits", "the", "respiratory", "chain", "complex", "1", "in", "mitochondria", "and", "this", "leads", "to", "an", "increase", "in", "ratio", "of", "AMP", "to", "ATP", ",", "thereby", "triggering", "activation", "of", "AMP", "activated", "protein", "kinase", "(", "AMPK", ")", ":", "the", "latter", "subsequently", "leads", "to", "mTOR", "inhibition", "[", "39-42", "]", "." ],
    "entities_indices" : [ [ 2, 3, 4 ], [ 19, 20 ], [ 38, 39 ], [ 40, 41 ], [ 51, 52 ], [ 59, 60 ] ]
  }, {
    "sentence_tokens" : [ "Studies", "involving", "metastatic", "melanoma", "patients", "established", "that", "vemurafenib", "caused", "tumor", "regression", "and", "significantly", "reduced", "risk", "of", "death", "compared", "to", "standard", "dacarbazine", "treatment", ",", "although", "patients", "often", "developed", "resistance", "and", "disease", "progression", "resumed", "after", "6-8", "months", "[", "29", ",", "30", "]", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 16, 17 ], [ 20, 21 ], [ 29, 30, 31 ] ]
  }, {
    "sentence_tokens" : [ "Metformin", "and", "combination", "treatment", "modulate", "signaling", "molecules", "MAPK", "and", "mTOR", "." ],
    "entities_indices" : [ [ 9, 10 ] ]
  }, {
    "sentence_tokens" : [ "Metformin", "and", "combination", "treatment", "modulate", "signaling", "molecules", "MAPK", "and", "mTOR", "." ],
    "entities_indices" : [ [ 7, 8 ] ]
  }, {
    "sentence_tokens" : [ "Sorafenib", "and", "lenvatinib", "both", "inhibit", "several", "protein", "kinases", "including", "vascular", "endothelial", "growth", "factor", "receptor", "(", "VEGFR", ")", "and", "platelet", "derived", "growth", "factor", "receptor", "(", "PDGFR", ")", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 15, 16 ], [ 19, 20, 21, 22 ], [ 19, 20, 21, 22, 23 ], [ 24, 25 ] ]
  }, {
    "sentence_tokens" : [ "Sorafenib", "and", "lenvatinib", "both", "inhibit", "several", "protein", "kinases", "including", "vascular", "endothelial", "growth", "factor", "receptor", "(", "VEGFR", ")", "and", "platelet", "derived", "growth", "factor", "receptor", "(", "PDGFR", ")", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 15, 16 ], [ 19, 20, 21, 22 ], [ 19, 20, 21, 22, 23 ], [ 24, 25 ] ]
  }, {
    "sentence_tokens" : [ "Sorafenib", "and", "lenvatinib", "both", "inhibit", "several", "protein", "kinases", "including", "vascular", "endothelial", "growth", "factor", "receptor", "(", "VEGFR", ")", "and", "platelet", "derived", "growth", "factor", "receptor", "(", "PDGFR", ")", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 15, 16 ], [ 19, 20, 21, 22 ], [ 19, 20, 21, 22, 23 ], [ 24, 25 ] ]
  }, {
    "sentence_tokens" : [ "Sorafenib", "and", "lenvatinib", "both", "inhibit", "several", "protein", "kinases", "including", "vascular", "endothelial", "growth", "factor", "receptor", "(", "VEGFR", ")", "and", "platelet", "derived", "growth", "factor", "receptor", "(", "PDGFR", ")", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 15, 16 ], [ 19, 20, 21, 22 ], [ 19, 20, 21, 22, 23 ], [ 24, 25 ] ]
  }, {
    "sentence_tokens" : [ "The", "rapamycin", ":", "FKBP12", "complex", "inhibits", "the", "signal", "transduction", "ability", "of", "mTOR", ",", "preventing", "activation", "of", "multiple", "targets", "required", "for", "progression", "through", "cell", "cycle", "and", "resulting", "in", "G1", "phase", "arrest", "." ],
    "entities_indices" : [ [ 1, 2 ], [ 7, 8, 9 ], [ 22, 23, 24 ], [ 27, 28, 29 ] ]
  }, {
    "sentence_tokens" : [ "The", "rapamycin", ":", "FKBP12", "complex", "inhibits", "the", "signal", "transduction", "ability", "of", "mTOR", ",", "preventing", "activation", "of", "multiple", "targets", "required", "for", "progression", "through", "cell", "cycle", "and", "resulting", "in", "G1", "phase", "arrest", "." ],
    "entities_indices" : [ [ 1, 2 ], [ 11, 12 ], [ 22, 23, 24 ], [ 27, 28, 29 ] ]
  }, {
    "sentence_tokens" : [ "The", "two", "mTOR", "inhibitors", "we", "chose", "are", "both", "clinically", "available", "with", "known", "pharmacokinetics", "and", "with", "somewhat", "differing", "mechanisms", "of", "action.Metformin", "transiently", "inhibits", "the", "respiratory", "chain", "complex", "1", "in", "mitochondria", "and", "this", "leads", "to", "an", "increase", "in", "ratio", "of", "AMP", "to", "ATP", ",", "thereby", "triggering", "activation", "of", "AMP", "activated", "protein", "kinase", "(", "AMPK", ")", ":", "the", "latter", "subsequently", "leads", "to", "mTOR", "inhibition", "[", "39-42", "]", "." ],
    "entities_indices" : [ [ 2, 3, 4 ], [ 19, 20 ], [ 38, 39 ], [ 46, 47, 48 ], [ 51, 52 ], [ 59, 60 ] ]
  }, {
    "sentence_tokens" : [ "Metformin", "caused", "decreased", "cell", "viability", "and", "increased", "apoptosis", "in", "BCPAP", "and", "BHP10-3SC", "papillary", "thyroid", "cells", "and", "inhibited", "BHP10-3SC", "tumor", "growth", "in", "nude", "mice", "." ],
    "entities_indices" : [ [ 3, 4, 5 ], [ 7, 8 ], [ 13, 14 ] ]
  }, {
    "sentence_tokens" : [ "Sorafenib", "also", "inhibits", "RAF", "kinases", "and", "lenvatinib", "inhibits", "fibroblast", "growth", "factor", "receptor", "(", "FGFR", ")", ",", "RET", ",", "and", "KIT", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 6, 7 ], [ 8, 9, 10, 11, 12 ], [ 13, 14 ], [ 16, 17 ] ]
  } ],
  "withoutRegulations" : [ {
    "sentence_tokens" : [ "Apoptosis", ",", "or", "programmed", "cell", "death", ",", "was", "measured", "in", "each", "of", "the", "thyroid", "cell", "lines", "following", "treatment", "with", "vemurafenib", ",", "metformin", ",", "and", "the", "combination", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 3, 4, 5, 6 ], [ 13, 14 ], [ 19, 20 ], [ 21, 22 ] ]
  }, {
    "sentence_tokens" : [ "Anti-proliferative", "effects", "of", "metformin", "in", "BCPAP", "cells", "may", "be", "driven", "through", "diminishment", "of", "mTOR", "expression.The", "concentration", "of", "2", "mM", "metformin", "used", "in", "this", "study", "is", "relatively", "high", "compared", "to", "expected", "human", "plasma", "levels", "of", "around", "10-40", "mu", "M", "after", "receiving", "a", "standard", "therapeutic", "dose", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 13, 14 ], [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "Microscopically", ",", "vemurafenib", "treated", "BCPAP", "cells", "show", "distinct", "signs", "of", "apoptosis", "including", "chromatin", "condensation", "and", "nuclear", "fragmentation", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 10, 11 ], [ 13, 14 ] ]
  }, {
    "sentence_tokens" : [ "mTOR", "inhibitors", "sensitize", "thyroid", "cancer", "cells", "to", "cytotoxic", "effect", "of", "vemurafenib", "." ],
    "entities_indices" : [ [ 0, 1, 2 ], [ 10, 11 ] ]
  }, {
    "sentence_tokens" : [ "Rapamycin", "serves", "as", "a", "direct", "specific", "inhibitor", "of", "mTOR", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 8, 9 ] ]
  }, {
    "sentence_tokens" : [ "Trypan", "blue", "exclusion", "assays", "were", "repeated", "at", "least", "once", "in", "triplicates", "." ],
    "entities_indices" : [ [ 0, 1, 2 ] ]
  }, {
    "sentence_tokens" : [ "Cellular", "viability", "and", "apoptosis", "were", "analyzed", "in", "thyroid", "cell", "lines", "by", "trypan", "blue", "exclusion", "and", "TUNEL", "assays", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 7, 8 ], [ 11, 12, 13 ] ]
  }, {
    "sentence_tokens" : [ "Further", "elucidation", "of", "the", "link", "between", "driver", "mutations", ",", "resistance", "to", "targeted", "therapy", "and", "metabolism", "may", "build", "upon", "new", "avenues", "for", "cancer", "therapies.Combination", "therapy", "with", "metformin", "and", "vemurafenib", "proved", "to", "be", "effective", "at", "inhibiting", "all", "thyroid", "cancer", "cell", "lines", "analyzed", ",", "including", "BCPAP", ",", "resistant", "BCPAP", ",", "and", "8505c", "." ],
    "entities_indices" : [ [ 14, 15 ], [ 25, 26 ], [ 27, 28 ] ]
  }, {
    "sentence_tokens" : [ "We", "conclude", "that", "combination", "of", "BRAFV600E", "and", "mTOR", "inhibition", "forms", "the", "basis", "of", "a", "treatment", "regimen", "that", "should", "be", "further", "investigated", "in", "in", "vivo", "model", "systems", "." ],
    "entities_indices" : [ [ 5, 6 ], [ 7, 8 ] ]
  }, {
    "sentence_tokens" : [ "Further", "research", "defining", "the", "wide", "ranging", "effects", "of", "metformin", "at", "different", "concentrations", "and", "within", "different", "cell", "types", "is", "needed.The", "prior", "investigation", "with", "melanoma", "found", "synergistic", "anti-proliferative", "effects", "of", "vemurafenib", "and", "metformin", "in", "the", "majority", "of", "BRAFV600E", "positive", "cell", "lines", ",", "although", "some", "antagonistic", "effects", "were", "also", "seen", "[", "46", "]", "." ],
    "entities_indices" : [ [ 8, 9 ], [ 22, 23 ], [ 28, 29 ], [ 30, 31 ], [ 35, 36 ] ]
  }, {
    "sentence_tokens" : [ "Combinations", "of", "vemurafenib", "and", "mTOR", "inhibitors", "should", "be", "further", "studied", "on", "human", "cancer", "xenografts", "on", "immunodeficient", "mice", ",", "to", "evaluate", "in", "vivo", "effects", "and", "potential", "clinical", "benefits", "for", "treatment", "of", "advanced", "thyroid", "cancer", "patients", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 4, 5, 6 ], [ 16, 17 ] ]
  }, {
    "sentence_tokens" : [ "Cells", "were", "then", "treated", "with", "+/-", "10", "mu", "M", "vemurafenib", "for", "36", "hours", "." ],
    "entities_indices" : [ [ 9, 10 ] ]
  }, {
    "sentence_tokens" : [ "Thyroid", "cells", "were", "allowed", "to", "grow", "in", "T75", "flasks", "until", "70", "%", "confluence", "." ],
    "entities_indices" : [ [ 0, 1 ] ]
  }, {
    "sentence_tokens" : [ "Studies", "in", "the", "laboratory", "have", "also", "confirmed", "growth-inhibitory", "effects", "of", "metformin", "on", "thyroid", "cancer", "cells", "[", "18", ",", "19", "]", "." ],
    "entities_indices" : [ [ 10, 11 ] ]
  }, {
    "sentence_tokens" : [ "The", "rationale", "behind", "targeting", "BRAFV600E", "kinase", "is", "that", "this", "protein", "is", "specific", "to", "cancer", "cells", "and", "drives", "the", "growth", "promoting", "MAPK", "pathway", "." ],
    "entities_indices" : [ [ 4, 5, 6 ], [ 20, 21 ] ]
  }, {
    "sentence_tokens" : [ "It", "is", "likely", "that", "activation", "of", "multiple", "growth", "promoting", "signaling", "pathways", "including", "MAPK", "and", "PI3K", "and", "Akt", "contributes", "to", "development", "of", "vemurafenib", "resistance", "." ],
    "entities_indices" : [ [ 12, 13 ], [ 14, 15 ], [ 16, 17 ], [ 21, 22 ] ]
  }, {
    "sentence_tokens" : [ "Thyroid", "cancer", "cells", "become", "dependent", "on", "BRAFV600E", "constitutive", "activation", "for", "growth", ",", "survival", ",", "and", "tumor", "progression", "." ],
    "entities_indices" : [ [ 6, 7 ], [ 15, 16 ] ]
  }, {
    "sentence_tokens" : [ "One", "phase", "II", "trial", "evaluated", "the", "efficacy", "and", "safety", "of", "everolimus", ",", "a", "rapamycin", "derivative", ",", "in", "advanced", "thyroid", "cancers", "and", "determined", "that", "the", "drug", "had", "some", "clinical", "benefit", "although", "further", "study", "is", "needed", "[", "27", "]", "." ],
    "entities_indices" : [ [ 10, 11 ], [ 13, 14 ], [ 18, 19 ] ]
  }, {
    "sentence_tokens" : [ "However", ",", "there", "are", "few", "treatment", "options", "available", "for", "patients", "with", "advanced", "disease", "including", "radioiodine", "resistant", "and", "metastatic", "differentiated", "thyroid", "cancer", "and", "anaplastic", "thyroid", "cancer", "." ],
    "entities_indices" : [ [ 22, 23, 24, 25 ] ]
  }, {
    "sentence_tokens" : [ "In", "cases", "of", "BRAFV600E", "positive", "colorectal", "cancers", ",", "inhibition", "of", "BRAFV600E", "alone", "was", "ineffective", ",", "largely", "due", "to", "feedback", "activation", "of", "epidermal", "growth", "factor", "receptor", "(", "EGFR", ")", "[", "31-34", "]", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 10, 11 ], [ 21, 22, 23, 24, 25 ], [ 26, 27 ] ]
  }, {
    "sentence_tokens" : [ "In", "BCPAP", ",", "the", "decrease", "in", "viability", "after", "combination", "treatment", "can", "be", "attributed", "largely", "to", "the", "percentage", "of", "apoptotic", "cells", "detected", "by", "TUNEL", "." ],
    "entities_indices" : [ [ 22, 23 ] ]
  }, {
    "sentence_tokens" : [ "Slides", "were", "viewed", "and", "images", "were", "captured", "using", "Axiovision", "Rel", "4.8", "on", "the", "Axiovert", "200", "M", "microscope", "(", "Carl", "Zeiss", "MicroImaging", ",", "Inc", ".,", "Thornwood", ",", "NY", ")", "." ],
    "entities_indices" : [ [ 9, 10 ] ]
  }, {
    "sentence_tokens" : [ "Dr.", "Norman", "L.", "Eberhardt", "(", "Mayo", "Clinic", ",", "Rochester", ",", "MN", ")", "generously", "gifted", "the", "Nthy-ori", "3-1", "cell", "line", "." ],
    "entities_indices" : [ [ 10, 11 ] ]
  }, {
    "sentence_tokens" : [ "Volumes", "containing", "10", "mu", "g", "protein", "per", "sample", "were", "subjected", "to", "12", "%", "SDS-polyacrylamide", "gel", "electrophoresis", "as", "in", "our", "prior", "studies", "[", "50", ",", "51", "]", "." ],
    "entities_indices" : [ [ 4, 5, 6 ] ]
  }, {
    "sentence_tokens" : [ "The", "resistant", "BCPAP", "and", "Nthy-ori", "3-1", "cells", "were", "not", "susceptible", "to", "rapamycin", "or", "the", "combination", "treatment", "in", "terms", "of", "viability", "(", "Figure", "4A", ",", "4C", ")", "." ],
    "entities_indices" : [ [ 11, 12 ] ]
  }, {
    "sentence_tokens" : [ "Exquisite", "sensitivity", "to", "combination", "treatment", "targeting", "BRAFV600E", "and", "a", "downstream", "integrative", "molecule", "such", "as", "mTOR", "may", "be", "seen", "in", "a", "defined", "population", "of", "cancer", "cells", ",", "as", "in", "the", "case", "of", "BCPAP", "cells.Sensitivity", "of", "differentiated", "papillary", "thyroid", "cancer", "cells", "to", "rapamycin", "and", "vemurafenib", "treatment", "could", "be", "exploited", "clinically", "by", "treating", "with", "combination", "therapy", "early", "on", "in", "a", "patient", "'s", "clinical", "course", ",", "before", "resistance", "to", "vemurafenib", "develops", "." ],
    "entities_indices" : [ [ 14, 15 ], [ 35, 36, 37, 38 ], [ 40, 41 ], [ 42, 43 ], [ 65, 66 ] ]
  }, {
    "sentence_tokens" : [ "We", "measured", "viability", "of", "several", "thyroid", "cell", "lines", "after", "treatment", "with", "vemurafenib", ",", "metformin", ",", "and", "the", "combination", "." ],
    "entities_indices" : [ [ 5, 6 ], [ 11, 12 ], [ 13, 14 ] ]
  }, {
    "sentence_tokens" : [ "Additionally", ",", "two", "individual", "case", "reports", "documented", "tumor", "regression", "in", "response", "to", "vemurafenib", "in", "a", "patient", "with", "anaplastic", "thyroid", "cancer", "and", "a", "patient", "with", "advanced", "papillary", "thyroid", "cancer", "[", "12", ",", "13", "]", "." ],
    "entities_indices" : [ [ 7, 8 ], [ 12, 13 ], [ 17, 18, 19, 20 ], [ 25, 26, 27, 28 ] ]
  }, {
    "sentence_tokens" : [ "Trypan", "blue", "exclusion", "assay", "." ],
    "entities_indices" : [ [ 0, 1, 2 ] ]
  }, {
    "sentence_tokens" : [ "Total", "cellular", "DNA", "was", "stained", "with", "DAPI", "." ],
    "entities_indices" : [ [ 6, 7 ] ]
  }, {
    "sentence_tokens" : [ "Induction", "of", "apoptosis", "was", "greatest", "in", "BCPAP", "and", "also", "occurred", "in", "8505c", "." ],
    "entities_indices" : [ [ 0, 1, 2, 3 ] ]
  }, {
    "sentence_tokens" : [ "Combination", "treatment", "with", "rapamycin", "and", "vemurafenib", "proved", "to", "be", "effective", "only", "in", "BCPAP", "papillary", "thyroid", "cancer", "cells", ",", "possibly", "due", "to", "rapamycin", "'s", "more", "targeted", "mechanism", "of", "action", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 5, 6 ], [ 13, 14, 15, 16 ], [ 21, 22 ] ]
  }, {
    "sentence_tokens" : [ "The", "metformin-vemurafenib", "combination", "further", "reduced", "8505c", "frequency", "of", "live", "cells", "to", "50", "%", "of", "untreated", "cells", ",", "and", "the", "number", "of", "viable", "cells", "was", "significantly", "lower", "than", "viable", "cells", "counted", "after", "treatment", "with", "metformin", "alone", "(", "Figure", "1D", ")", "." ],
    "entities_indices" : [ [ 33, 34 ] ]
  }, {
    "sentence_tokens" : [ "In", "a", "series", "of", "viability", "assays", ",", "rapamycin", "treatment", "alone", "had", "no", "significant", "effect", "on", "cell", "viability", "in", "all", "thyroid", "cell", "lines", "analyzed", "(", "Figure", "4", ")", "." ],
    "entities_indices" : [ [ 7, 8 ], [ 15, 16, 17 ], [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "Actions", "of", "metformin", "in", "cancer", "cells", "may", "also", "include", "reducing", "expression", "of", "key", "enzymes", "involved", "in", "fatty", "acid", "synthesis", "as", "well", "as", "membrane", "tyrosine", "kinase", "receptors", "[", "42-44", "]", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 16, 17, 18, 19 ] ]
  }, {
    "sentence_tokens" : [ "However", ",", "in", "the", "combination", "treatment", "group", ",", "BCPAP", "cells", "demonstrated", "increased", "frequency", "of", "apoptosis", "with", "31.0", "%", "of", "cells", "within", "the", "gated", "area", "(", "Figure", "2A", ",", "2B", ")", "." ],
    "entities_indices" : [ [ 14, 15 ] ]
  }, {
    "sentence_tokens" : [ "Although", "8505c", "anaplastic", "thyroid", "cancer", "cells", "were", "unaffected", "by", "treatment", "with", "vemurafenib", ",", "metformin", "alone", "decreased", "their", "viability", "significantly", "to", "75", "%", "that", "of", "untreated", "." ],
    "entities_indices" : [ [ 2, 3, 4, 5 ], [ 11, 12 ], [ 13, 14 ] ]
  }, {
    "sentence_tokens" : [ "The", "combination", "of", "vemurafenib", "and", "metformin", "is", "an", "example", "of", "a", "strategy", "to", "combine", "therapies", "that", "target", "both", "the", "driver", "mutation", "BRAFV600E", "and", "more", "broadly", "inhibit", "critical", "cellular", "signaling", "pathways", "related", "to", "metabolism", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 5, 6 ], [ 32, 33 ] ]
  }, {
    "sentence_tokens" : [ "Effects", "on", "mTOR", "also", "varied", "among", "thyroid", "cancer", "cell", "lines", ",", "as", "total", "mTOR", "expression", "decreased", "in", "response", "to", "metformin", "in", "BCPAP", "and", "increased", "in", "8505c", "anaplastic", "cells", "(", "Figure", "3", ")", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 13, 14 ], [ 17, 18, 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "The", "drug", "combination", "treated", "cells", "visualized", "support", "the", "finding", "of", "increased", "TUNEL", "positive", "staining", "measured", "by", "flow", "cytometry", "(", "Figure", "5C", ")", "." ],
    "entities_indices" : [ [ 11, 12 ] ]
  }, {
    "sentence_tokens" : [ "The", "drug", "vemurafenib", "has", "also", "recently", "proved", "to", "be", "useful", "in", "treating", "advanced", "thyroid", "cancer", "patients", "in", "clinical", "trials.In", "an", "earlier", "study", ",", "one", "patient", "with", "metastatic", "thyroid", "cancer", "experienced", "a", "partial", "response", "including", "reduced", "pulmonary", "lesions", "after", "treatment", "with", "vemurafenib", ",", "and", "the", "two", "other", "patients", "had", "stable", "disease", "[", "11", "]", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 40, 41 ] ]
  }, {
    "sentence_tokens" : [ "One", "study", "concluded", "that", "BRAF", "inhibition", "resistance", "pathways", "converge", "to", "regulate", "translation", "of", "mRNAs", "through", "formation", "of", "the", "eIF4F", "initiation", "complex", "[", "16", "]", "." ],
    "entities_indices" : [ [ 4, 5 ], [ 11, 12 ], [ 18, 19 ] ]
  }, {
    "sentence_tokens" : [ "Terminal", "Deoxynucleotide", "Transferase", "dUTP", "Nick", "End", "Labeling", "(", "TUNEL", ")", "was", "used", "to", "identify", "DNA", "strand", "breaks", "that", "are", "characteristic", "of", "apoptotic", "cells", "[", "28", "]", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 3, 4 ], [ 5, 6 ], [ 8, 9 ] ]
  }, {
    "sentence_tokens" : [ "In", "8505c", ",", "the", "difference", "in", "viability", "between", "vemurafenib", "treated", "and", "combination", "treated", "samples", "was", "not", "significant", "(", "Figure", "4D", ")", "." ],
    "entities_indices" : [ [ 8, 9 ] ]
  }, {
    "sentence_tokens" : [ "As", "expected", ",", "these", "cells", "were", "relatively", "resistant", "to", "treatment", "with", "vemurafenib", "alone", "compared", "to", "normal", "BCPAP", "(", "Figure", "1B", ",", "1C", ")", "." ],
    "entities_indices" : [ [ 11, 12 ] ]
  }, {
    "sentence_tokens" : [ "Concordant", "with", "results", "of", "viability", "assays", ",", "combination", "treatment", "caused", "a", "greatly", "enhanced", "frequency", "of", "apoptosis", "compared", "to", "vemurafenib", "treatment", "alone", "." ],
    "entities_indices" : [ [ 15, 16 ], [ 18, 19 ] ]
  }, {
    "sentence_tokens" : [ "Thyroid", "cell", "lines", "used", "in", "this", "study", "include", "a", "normal", "transformed", "line", "(", "Nthy-ori", "3-1", ")", ",", "a", "papillary", "thyroid", "cancer", "cell", "line", "(", "BCPAP", ")", ",", "and", "an", "anaplastic", "thyroid", "cancer", "cell", "line", "(", "8505c", ")", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 18, 19, 20, 21 ], [ 29, 30, 31, 32 ] ]
  }, {
    "sentence_tokens" : [ "The", "second", "combination", "of", "vemurafenib", "and", "rapamycin", "amplified", "cell", "death", "in", "BCPAP", "cells", "." ],
    "entities_indices" : [ [ 4, 5 ], [ 6, 7 ], [ 8, 9, 10 ] ]
  }, {
    "sentence_tokens" : [ "Inhibition", "of", "mTOR", "signaling", "with", "rapamycin", "in", "combination", "with", "inhibition", "of", "the", "driver", "mutated", "kinase", "BRAFV600E", "with", "vemurafenib", "in", "thyroid", "cancer", "may", "result", "in", "more", "profound", "anti-proliferative", "effects", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 5, 6 ], [ 17, 18 ] ]
  }, {
    "sentence_tokens" : [ "For", "the", "rapamycin", "experiment", ",", "the", "same", "protocol", "was", "followed", "except", "cells", "were", "treated", "for", "24", "hours", "with", "phenol-red-free", "RPMI", "containing", "5", "%", "charcoal", "dextran", "treated", "FBS", "for", "24", "hours", "and", "then", "this", "media", "was", "replaced", "with", "fresh", "media", "containing", "+/-", "10", "mu", "M", "vemurafenib", ",", "+/-", "1", "mu", "M", "rapamycin", "for", "36", "hours", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 23, 24 ], [ 24, 25 ], [ 26, 27 ], [ 44, 45 ], [ 50, 51 ] ]
  }, {
    "sentence_tokens" : [ "Data", "highlights", "a", "connection", "of", "metformin", "to", "cell", "signaling", "pathways", "." ],
    "entities_indices" : [ [ 5, 6 ] ]
  }, {
    "sentence_tokens" : [ "A", "likely", "explanation", "is", "that", "decreases", "in", "cell", "viability", "may", "indicate", "decreased", "growth", "rate", "in", "response", "to", "treatment", ",", "in", "addition", "to", "cell", "death", "." ],
    "entities_indices" : [ [ 7, 8, 9 ], [ 22, 23, 24 ] ]
  }, {
    "sentence_tokens" : [ "As", "in", "the", "BCPAP", "cells", ",", "a", "greater", "than", "additive", "effect", "in", "terms", "of", "induction", "of", "apoptosis", "was", "observed", "in", "the", "8505c", "cells", "in", "response", "to", "combination", "treatment", "with", "metformin", "and", "vemurafenib", "." ],
    "entities_indices" : [ [ 14, 15, 16, 17 ], [ 29, 30 ], [ 31, 32 ] ]
  }, {
    "sentence_tokens" : [ "We", "found", "the", "percentage", "of", "apoptotic", "cells", "increased", "in", "both", "vemurafenib", "and", "combination", "treatment", "groups", "compared", "to", "untreated", "cultures", "(", "Figure", "5A", ",", "5B", ")", "." ],
    "entities_indices" : [ [ 10, 11 ], [ 23, 24 ] ]
  }, {
    "sentence_tokens" : [ "Complete", "media", "was", "replaced", "with", "5", "%", "charcoal", "dextran", "treated", "FBS", "+/-", "2", "mM", "metformin", "and", "plates", "were", "incubated", "for", "24", "hours", "." ],
    "entities_indices" : [ [ 7, 8 ], [ 8, 9 ], [ 10, 11 ], [ 14, 15 ] ]
  }, {
    "sentence_tokens" : [ "Most", "cases", "of", "thyroid", "cancer", "are", "treated", "successfully", "with", "surgical", "resection", ",", "radioiodine", ",", "and", "thyroid", "hormone", "therapy", "." ],
    "entities_indices" : [ [ 15, 16, 17 ] ]
  }, {
    "sentence_tokens" : [ "The", "viability", "(", "trypan", "blue", "exclusion", ")", "assay", "detects", "cells", "with", "impaired", "integrity", "of", "plasma", "membrane", "that", "leads", "to", "inability", "to", "exclude", "cationic", "dyes", "." ],
    "entities_indices" : [ [ 3, 4, 5 ] ]
  }, {
    "sentence_tokens" : [ "One", "study", "found", "that", "treatment", "with", "metformin", "in", "diabetic", "patients", "with", "thyroid", "cancer", "resulted", "in", "smaller", "tumor", "size", "and", "greater", "chance", "of", "complete", "remission", "[", "17", "]", "." ],
    "entities_indices" : [ [ 6, 7 ], [ 16, 17 ] ]
  }, {
    "sentence_tokens" : [ "Interestingly", ",", "both", "the", "resistant", "BCPAP", "cells", "and", "the", "inherently", "resistant", "anaplastic", "8505c", "cells", "demonstrated", "a", "profound", "inhibition", "of", "phospho-MAPK", "expression", "." ],
    "entities_indices" : [ [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "Between", "the", "vemurafenib", "treated", "sample", "and", "the", "metformin", "treated", "sample", "the", "number", "of", "apoptotic", "cells", "detected", "by", "this", "assay", "varied", "only", "slightly", ",", "at", "12.8", "%", "and", "9.33", "%", "of", "total", "cells", ",", "respectively", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 7, 8 ] ]
  }, {
    "sentence_tokens" : [ "Thus", ",", "resistant", "BCPAP", "cells", "were", "susceptible", "to", "growth-inhibitory", "effects", "of", "the", "combination", "treatment", ",", "although", "overt", "apoptosis", "was", "not", "detected", "at", "this", "time", "point.It", "should", "be", "noted", "that", "the", "apparent", "discordance", "between", "the", "viability", "and", "apoptosis", "assays", "may", "also", "stem", "from", "the", "different", "end-points", "being", "measuring", "by", "each", "." ],
    "entities_indices" : [ [ 17, 18 ], [ 36, 37 ] ]
  }, {
    "sentence_tokens" : [ "Vemurafenib", ",", "a", "BRAFV600E", "inhibitor", ",", "has", "shown", "promise", "in", "clinical", "trials", "although", "cellular", "resistance", "occurs", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 3, 4, 5 ] ]
  }, {
    "sentence_tokens" : [ "Each", "well", "contained", "200,000", "cells", "(", "8505c", ")", "or", "300,000", "cells", "(", "Nthy-ori", "3-1", ",", "BCPAP", ",", "resistant", "BCPAP", ")", "in", "2", "mL", "media", "at", "the", "start", "of", "the", "experiment", "." ],
    "entities_indices" : [ [ 12, 13, 14 ], [ 22, 23 ], [ 26, 27 ] ]
  }, {
    "sentence_tokens" : [ "Off-label", "use", "of", "vemurafenib", "for", "17", "patients", "with", "BRAFV600E", "positive", "advanced", "papillary", "thyroid", "cancer", "was", "reviewed", "retrospectively", "and", "found", "to", "be", "effective", "and", "well", "tolerated", "[", "14", "]", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 11, 12, 13, 14 ] ]
  }, {
    "sentence_tokens" : [ "Combination", "therapy", "including", "BRAFV600E", "inhibitors", "is", "a", "promising", "option", "to", "delay", "or", "prevent", "resistance", "and", "further", "improve", "therapy", "for", "BRAFV600E", "positive", "thyroid", "cancer", "patients", "." ],
    "entities_indices" : [ [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "Along", "with", "inhibition", "of", "mTOR", "signaling", ",", "there", "are", "several", "mechanisms", "proposed", "for", "anti-cancer", "effects", "of", "metformin", "including", "STAT3", "inhibition", "leading", "to", "induction", "of", "apoptosis", "and", "effects", "on", "cancer", "related", "miRNAs", "[", "20", "]", "." ],
    "entities_indices" : [ [ 4, 5 ], [ 16, 17 ], [ 18, 19 ], [ 22, 23, 24, 25 ] ]
  }, {
    "sentence_tokens" : [ "In", "order", "to", "create", "vemurafenib", "resistant", "BCPAP", "cells", ",", "cells", "were", "treated", "for", "24", "hours", "with", "increasing", "concentrations", "of", "vemurafenib", "(", "Chemietek", ",", "Indianapolis", ",", "IN", ")", "up", "to", "16", "mu", "M", ",", "subcultured", "and", "allowed", "to", "grow", "to", "70", "%", "confluence", "before", "the", "next", "treatment", "." ],
    "entities_indices" : [ [ 4, 5 ], [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "Another", "cell", "line", "evaluated", "was", "resistant", "BCPAP", ",", "which", "was", "created", "in", "the", "laboratory", "by", "exposing", "BCPAP", "cells", "to", "increasing", "concentrations", "of", "vemurafenib", "." ],
    "entities_indices" : [ [ 22, 23 ] ]
  }, {
    "sentence_tokens" : [ "While", "most", "apoptotic", "cells", "were", "TUNEL-(", "Alexa", "Fluor", "488", ")", "-", "positive", ",", "following", "some", "treatments", "they", "were", "also", "identified", "as", "the", "cells", "with", "fractional", "DNA", "content", "(", "\"", "sub-G1", "\"", "cells", ")", "[", "28", ",", "48", "]", "." ],
    "entities_indices" : [ [ 6, 7, 8, 9 ] ]
  }, {
    "sentence_tokens" : [ "It", "is", "noteworthy", "that", "the", "combination", "of", "rapamycin", "and", "vemurafenib", "resulted", "in", "very", "marked", "induction", "of", "apoptosis", "in", "BCPAP", ",", "accounting", "for", "the", "decrease", "in", "viability", "." ],
    "entities_indices" : [ [ 7, 8 ], [ 9, 10 ], [ 14, 15, 16, 17 ] ]
  }, {
    "sentence_tokens" : [ "Cells", "were", "washed", "with", "PBS", "twice", "and", "resuspended", "in", "70", "%", "ethanol", "." ],
    "entities_indices" : [ [ 11, 12 ] ]
  }, {
    "sentence_tokens" : [ "Membranes", "were", "blocked", "with", "5", "%", "milk", "in", "TBST", "(", "10", "mM", "Tris-HCl", ",", "pH", "7.5", ",", "200", "mM", "NaCl", ",", "0.05", "%", "Tween-20", ")", "for", "1.5", "hours", "at", "room", "temperature", "and", "then", "incubated", "overnight", "in", "primary", "antibodies", "(", "Cell", "Signaling", ")", "at", "4", "degrees", "Celsius", "." ],
    "entities_indices" : [ [ 14, 15 ], [ 19, 20 ], [ 23, 24 ] ]
  }, {
    "sentence_tokens" : [ "These", "effects", "were", "attributed", "to", "activation", "of", "AMP", "kinase", "and", "inhibition", "of", "growth", "promoting", "Akt", "and", "mTOR", "[", "19", "]", "." ],
    "entities_indices" : [ [ 7, 8 ], [ 14, 15 ], [ 16, 17 ] ]
  }, {
    "sentence_tokens" : [ "In", "addition", ",", "treatment", "with", "metformin", "alone", "and", "with", "combination", "treatment", "of", "vemurafenib", "and", "metformin", "decreased", "frequency", "of", "viable", "BCPAP", "cells", "to", "approximately", "50", "%", "of", "untreated", "cells", "(", "Figure", "1B", ")", "." ],
    "entities_indices" : [ [ 5, 6 ], [ 12, 13 ], [ 14, 15 ] ]
  }, {
    "sentence_tokens" : [ "It", "has", "been", "proposed", "that", "resistance", "to", "targeted", "therapy", "can", "be", "mediated", "by", "rewiring", "of", "cellular", "metabolism", "[", "45", "]", "." ],
    "entities_indices" : [ [ 15, 16, 17 ] ]
  }, {
    "sentence_tokens" : [ "Short-term", "treatment", "with", "BRAFV600E", "inhibitors", "has", "drastic", "anti-proliferative", "effects", "on", "mutated", "thyroid", "cancer", "cells", "including", "induction", "of", "apoptosis", "[", "8-10", "]", "." ],
    "entities_indices" : [ [ 15, 16, 17, 18 ] ]
  }, {
    "sentence_tokens" : [ "We", "hypothesized", "that", "the", "combination", "treatment", "of", "vemurafenib", "with", "rapamycin", ",", "similar", "as", "with", "metformin", ",", "may", "also", "lead", "to", "enhanced", "cytotoxic", "effects", "in", "thyroid", "cancer", "cell", "lines", "." ],
    "entities_indices" : [ [ 7, 8 ], [ 9, 10 ], [ 14, 15 ] ]
  }, {
    "sentence_tokens" : [ "Although", "limited", "to", "an", "in", "vitro", "system", ",", "our", "study", "provides", "evidence", "that", "combination", "of", "targeted", "BRAFV600E", "inhibition", "with", "broader", "inhibition", "provided", "by", "metformin", "causes", "greater", "than", "additive", "inhibition", "of", "thyroid", "cancer", "cell", "growth", "and", "induction", "of", "apoptosis", "." ],
    "entities_indices" : [ [ 23, 24 ], [ 32, 33, 34 ], [ 35, 36, 37, 38 ] ]
  }, {
    "sentence_tokens" : [ "It", "has", "also", "been", "researched", "as", "an", "anti-cancer", "agent", "due", "to", "its", "anti-proliferative", "effects", "which", "are", "more", "potent", "than", "its", "immunosuppressive", "effects", "in", "terms", "of", "tumor", "growth", "[", "21", "]", "." ],
    "entities_indices" : [ [ 25, 26 ] ]
  }, {
    "sentence_tokens" : [ "For", "the", "rapamycin", "experiment", ",", "the", "same", "protocol", "was", "followed", "except", "cells", "were", "treated", "for", "24", "hours", "with", "phenol-red-free", "RPMI", "containing", "5", "%", "charcoal", "dextran", "treated", "FBS", "and", "then", "media", "was", "replaced", "with", "fresh", "media", "containing", "+/-", "10", "mu", "M", "vemurafenib", "and", "+/-", "1", "mu", "M", "rapamycin", "for", "36", "hours", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 23, 24 ], [ 24, 25 ], [ 26, 27 ], [ 40, 41 ], [ 46, 47 ] ]
  }, {
    "sentence_tokens" : [ "Rapamycin-vemurafenib", "combination", "treatment", "significantly", "decreases", "viability", "compared", "to", "vemurafenib", "alone", "in", "BCPAP", "cells", "." ],
    "entities_indices" : [ [ 8, 9 ] ]
  }, {
    "sentence_tokens" : [ "All", "cell", "lines", "were", "cultured", "in", "Rosswell", "Park", "Memorial", "Institute", "(", "RPMI", ")", "-1640", "supplemented", "with", "10", "%", "fetal", "bovine", "serum", "(", "FBS", ")", ",", "penicillin", "10", ",", "000", "IU/mL", ",", "streptomycin", "10", ",", "000", "mu", "g/mL", ",", "and", "2", "mM", "L-glutamine", "." ],
    "entities_indices" : [ [ 22, 23 ], [ 25, 26 ], [ 31, 32 ], [ 41, 42 ] ]
  }, {
    "sentence_tokens" : [ "After", "treatment", ",", "cells", "were", "collected", "by", "gentle", "scraping", "with", "cell", "scrapers", ",", "subjected", "to", "radioimmunoprecipitation", "assay", "buffer", "(", "50mM", "Tris-HCl", "[", "pH", "7.4", "]", ",", "150mM", "NaCl", ",", "0.2", "%", "sodium", "deoxycholate", ",", "0.1", "%", "sodium", "dodecyl", "sulfate", "(", "SDS", ")", ",", "0.5", "%", "NP40", ",", "and", "1", "mu", "M", "Pefabloc", ")", "and", "vortexed", "every", "5", "minutes", "for", "30", "minutes", "over", "ice", "." ],
    "entities_indices" : [ [ 22, 23 ], [ 27, 28 ], [ 31, 32, 33 ], [ 36, 37, 38, 39 ], [ 40, 41 ] ]
  }, {
    "sentence_tokens" : [ "Thyroid", "cells", "were", "plated", "in", "6-well", "plates", "at", "300,000", "cells", "per", "well", "(", "Nthy-ori", "3-1", ",", "BCPAP", ",", "and", "resistant", "BCPAP", ")", "or", "200,000", "cells", "per", "well", "(", "8505c", ")", "and", "allowed", "to", "adhere", "overnight", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 13, 14, 15 ] ]
  }, {
    "sentence_tokens" : [ "Immune", "checkpoint", "inhibitors", "combined", "with", "targeted", "therapy", "are", "also", "being", "considered", "in", "melanoma", "[", "38", "]", "." ],
    "entities_indices" : [ [ 12, 13 ] ]
  }, {
    "sentence_tokens" : [ "Effects", "of", "metformin", "on", "thyroid", "cancer", "cell", "signaling", "pathways", "are", "largely", "unknown", "." ],
    "entities_indices" : [ [ 2, 3 ] ]
  }, {
    "sentence_tokens" : [ "Metformin", "treated", "8505c", "cells", "demonstrated", "a", "slight", "increase", "in", "apoptosis", "(", "4.8", "%", ")", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 9, 10 ] ]
  }, {
    "sentence_tokens" : [ "This", "combination", "was", "also", "found", "to", "be", "active", "in", "vemurafenib", "resistant", "BCPAP", "cells", "." ],
    "entities_indices" : [ [ 9, 10 ] ]
  }, {
    "sentence_tokens" : [ "Since", "mammalian", "target", "of", "rapamycin", "(", "mTOR", ")", "is", "a", "major", "regulator", "of", "translation", "via", "eIF4F", "initiation", "complex", "formation", "and", "receives", "input", "from", "cell", "signaling", "pathways", ",", "it", "is", "also", "a", "rational", "target", "for", "combination", "therapy.In", "this", "study", "we", "investigated", "the", "combination", "of", "vemurafenib", "and", "mTOR", "inhibitors", ",", "metformin", "and", "rapamycin", ",", "which", "has", "not", "yet", "been", "explored", "in", "thyroid", "cancer", "." ],
    "entities_indices" : [ [ 1, 2, 3, 4, 5 ], [ 6, 7 ], [ 13, 14 ], [ 15, 16 ], [ 43, 44 ], [ 45, 46, 47 ], [ 48, 49 ], [ 50, 51 ] ]
  }, {
    "sentence_tokens" : [ "Percentage", "of", "apoptotic", "cells", "increased", "from", "about", "40", "%", "with", "vemurafenib", "alone", "to", "70", "%", "with", "the", "combination", "of", "rapamycin", "and", "vemurafenib", "(", "Figure", "5B", ")", "." ],
    "entities_indices" : [ [ 10, 11 ], [ 19, 20 ], [ 21, 22 ] ]
  }, {
    "sentence_tokens" : [ "In", "this", "assay", ",", "there", "were", "few", "apoptotic", "cells", "detected", "in", "the", "untreated", "and", "rapamycin", "treated", "BCPAP", "cells", "(", "Figure", "5A", ",", "5B", ")", "." ],
    "entities_indices" : [ [ 14, 15 ], [ 22, 23 ] ]
  }, {
    "sentence_tokens" : [ "It", "was", "proposed", "that", "low", "expression", "levels", "of", "OCT1", "transporter", "in", "cultured", "cells", "may", "account", "for", "this", "difference", ",", "which", "may", "also", "be", "the", "case", "for", "our", "thyroid", "cancer", "cell", "lines", "[", "46", "]", "." ],
    "entities_indices" : [ [ 8, 9 ] ]
  }, {
    "sentence_tokens" : [ "Interestingly", ",", "vemurafenib", "resistant", "BCPAP", "cells", "also", "appeared", "to", "be", "completely", "resistant", "to", "metformin", ",", "as", "there", "was", "no", "significant", "change", "in", "their", "viability", "in", "response", "to", "treatment", "with", "this", "drug", "as", "a", "single", "agent", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 13, 14 ] ]
  }, {
    "sentence_tokens" : [ "BRAFV600E", "mutation", "is", "also", "found", "in", "melanoma", "and", "colorectal", "cancer", "." ],
    "entities_indices" : [ [ 0, 1, 2 ], [ 6, 7 ] ]
  }, {
    "sentence_tokens" : [ "The", "apoptotic", "(", "TUNEL", ")", "assay", "detects", "cells", "with", "fragmented", "DNA", ";", "in", "the", "case", "of", "early-", "or", "mid-", "stage", "of", "apoptosis", "such", "cells", "have", "well", "preserved", "plasma", "membrane", "and", "do", "exclude", "trypan", "blue", "[", "28", "]", "." ],
    "entities_indices" : [ [ 21, 22 ], [ 32, 33, 34 ] ]
  }, {
    "sentence_tokens" : [ "This", "suggests", "a", "role", "for", "metformin", "in", "interfering", "with", "signal", "transduction", "when", "combined", "with", "BRAFV600E", "inhibition", "and", "may", "account", "for", "decreased", "growth", "in", "viability", "assays", "." ],
    "entities_indices" : [ [ 5, 6 ], [ 9, 10, 11 ] ]
  }, {
    "sentence_tokens" : [ "Complete", "media", "was", "replaced", "with", "phenol-red-free", "RPMI", "containing", "5", "%", "charcoal", "dextran", "treated", "FBS", "+/-", "2", "mM", "metformin", "and", "plates", "were", "incubated", "for", "24", "hours", "." ],
    "entities_indices" : [ [ 10, 11 ], [ 11, 12 ], [ 13, 14 ], [ 17, 18 ] ]
  }, {
    "sentence_tokens" : [ "Researchers", "are", "now", "investigating", "combinations", "of", "targeted", "inhibitors", ",", "including", "dabrafenib", "(", "BRAFV600E", "inhibitor", ")", "and", "lapatinib", "(", "HER2", "and", "neu", "and", "EGFR", "inhibitor", ")", "in", "refractory", "and", "inoperable", "BRAFV600E", "positive", "thyroid", "cancer", "." ],
    "entities_indices" : [ [ 16, 17 ], [ 18, 19 ], [ 20, 21 ], [ 22, 23, 24 ] ]
  }, {
    "sentence_tokens" : [ "Cells", "were", "treated", "with", "vemurafenib", "concentrations", "of", "10", "mu", "M", ",", "12", "mu", "M", ",", "14", "mu", "M", ",", "and", "16", "mu", "M", "over", "a", "period", "of", "45", "days", "." ],
    "entities_indices" : [ [ 4, 5 ] ]
  }, {
    "sentence_tokens" : [ "Clinical", "studies", "thus", "far", "include", "targeting", "molecules", "that", "fall", "directly", "within", "the", "canonical", "MAPK", "pathway", ",", "such", "as", "MEK", "in", "melanoma", "[", "35", ",", "36", "]", "and", "molecules", "that", "are", "membrane", "receptors", "activated", "due", "to", "feedback", "mechanisms", ",", "such", "as", "EGFR", "in", "colorectal", "cancer", "[", "37", "]", "." ],
    "entities_indices" : [ [ 13, 14 ], [ 18, 19 ], [ 20, 21 ], [ 40, 41 ] ]
  }, {
    "sentence_tokens" : [ "However", ",", "the", "combination", "treatment", "increased", "BCPAP", "apoptosis", "compared", "to", "vemurafenib", "alone", "without", "a", "significant", "change", "in", "viability", "between", "the", "two", "groups", "." ],
    "entities_indices" : [ [ 7, 8 ], [ 10, 11 ] ]
  }, {
    "sentence_tokens" : [ "Rapamycin", "is", "an", "immunosuppressant", "used", "to", "prevent", "organ", "transplant", "rejection", ",", "especially", "in", "kidney", "transplants", "." ],
    "entities_indices" : [ [ 0, 1 ] ]
  }, {
    "sentence_tokens" : [ "Metformin-vemurafenib", "combination", "treatment", "significantly", "decreases", "viability", "in", "vemurafenib", "resistant", "BCPAP", "cells", "." ],
    "entities_indices" : [ [ 7, 8 ] ]
  }, {
    "sentence_tokens" : [ "In", "2013", ",", "the", "kinase", "inhibitor", "sorafenib", "became", "the", "first", "drug", "since", "doxorubicin", "to", "be", "FDA", "approved", "in", "the", "past", "40", "years", "for", "treatment", "of", "radioiodine", "resistant", "metastatic", "well", "differentiated", "thyroid", "cancer", "[", "1", "]", "." ],
    "entities_indices" : [ [ 6, 7 ], [ 12, 13 ], [ 15, 16 ] ]
  }, {
    "sentence_tokens" : [ "Apoptotic", "cells", "made", "up", "70", "%", "of", "all", "detected", "BCPAP", "cells", "and", "there", "was", "a", "large", "population", "of", "cells", "intensely", "stained", "with", "TUNEL", ",", "indicative", "of", "intensive", "DNA", "fragmentation", "and", "advanced", "progression", "of", "apoptosis", "[", "28", "]", "." ],
    "entities_indices" : [ [ 33, 34 ] ]
  }, {
    "sentence_tokens" : [ "To", "further", "investigate", "cytotoxic", "effects", "in", "BCPAP", "cells", "in", "response", "to", "rapamycin", "and", "vemurafenib", ",", "we", "conducted", "another", "TUNEL", "based", "assay", "to", "evaluate", "apoptosis", "." ],
    "entities_indices" : [ [ 9, 10, 11, 12 ], [ 13, 14 ], [ 23, 24 ] ]
  }, {
    "sentence_tokens" : [ "Rapamycin", "forms", "a", "complex", "with", "cytosolic", "FK", "binding", "protein", "12", "(", "FKBP12", ")", "and", "this", "complex", "serves", "as", "a", "direct", "and", "specific", "inhibitor", "of", "mTOR", "[", "22-26", "]", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 5, 6, 7, 8, 9, 10 ], [ 11, 12 ], [ 24, 25 ] ]
  }, {
    "sentence_tokens" : [ "However", ",", "the", "cell", "viability", "decreased", "significantly", ",", "to", "about", "50", "%", "of", "untreated", "cells", "after", "treatment", "with", "the", "combination", "of", "metformin", "and", "vemurafenib", "(", "Figure", "1C", ")", "." ],
    "entities_indices" : [ [ 3, 4, 5 ], [ 21, 22 ], [ 23, 24 ] ]
  }, {
    "sentence_tokens" : [ "Cells", "in", "solution", "were", "subjected", "to", "the", "APO-BRDU", "protocol", "(", "Phoenix", "Flow", "Systems", ",", "Inc", ".,", "San", "Diego", ",", "CA", ")", "." ],
    "entities_indices" : [ [ 7, 8, 9 ], [ 16, 17 ], [ 19, 20 ] ]
  }, {
    "sentence_tokens" : [ "Intensity", "of", "cellular", "fluorescence", "was", "measured", "using", "a", "MoFlo", "XDP", "(", "Beckman-Coulter", ",", "Brea", ",", "CA", ")", "high", "speed", "flow", "cytometer", "and", "sorter", "." ],
    "entities_indices" : [ [ 9, 10 ], [ 15, 16 ] ]
  }, {
    "sentence_tokens" : [ "In", "addition", ",", "anaplastic", "thyroid", "cancer", "patients", "face", "an", "average", "life", "expectancy", "of", "less", "than", "one", "year", "." ],
    "entities_indices" : [ [ 3, 4, 5, 6 ] ]
  }, {
    "sentence_tokens" : [ "In", "regard", "to", "resistant", "BCPAP", "cells", ",", "viability", "decreased", "significantly", "without", "a", "corresponding", "increase", "in", "apoptosis", "after", "combination", "treatment", "." ],
    "entities_indices" : [ [ 15, 16 ] ]
  }, {
    "sentence_tokens" : [ "Metformin", "or", "rapamycin", "adjuvant", "treatment", "may", "provide", "clinical", "benefits", "with", "minimal", "side", "effects", "to", "BRAFV600E", "positive", "advanced", "thyroid", "cancer", "patients", "treated", "with", "vemurafenib", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 2, 3 ], [ 22, 23 ] ]
  }, {
    "sentence_tokens" : [ "In", "the", "BCPAP", "papillary", "thyroid", "cancer", "cells", ",", "some", "degree", "of", "apoptosis", "occurred", "in", "the", "untreated", "group", "(", "11.3", "%", ")", "revealing", "the", "background", "level", "of", "cell", "death", "under", "experimental", "conditions", "." ],
    "entities_indices" : [ [ 3, 4, 5, 6 ], [ 11, 12 ], [ 26, 27, 28 ] ]
  }, {
    "sentence_tokens" : [ "In", "another", "study", ",", "a", "similar", "biguanide", "drug", ",", "phenformin", ",", "demonstrated", "cooperative", "effects", "to", "inhibit", "proliferation", "when", "combined", "with", "BRAFV600E", "inhibition", "in", "melanoma", "cells", "and", "also", "delayed", "development", "of", "resistance", "[", "47", "]", "." ],
    "entities_indices" : [ [ 6, 7 ], [ 9, 10 ], [ 16, 17 ], [ 23, 24 ] ]
  }, {
    "sentence_tokens" : [ "We", "also", "detected", "a", "large", "population", "of", "cells", "with", "high", "TUNEL", "staining", "in", "the", "combination", "group", "seen", "in", "Figure", "5A", ",", "indicating", "a", "relative", "abundance", "of", "exposed", "3", "'-hydroxyl", "ends", "of", "the", "DNA", "strand", "breaks", "compared", "to", "cells", "treated", "with", "vemurafenib", "alone", "." ],
    "entities_indices" : [ [ 40, 41 ] ]
  }, {
    "sentence_tokens" : [ "We", "investigated", "a", "second", "possible", "combination", "therapy", "of", "rapamycin", "and", "vemurafenib", "in", "thyroid", "cells", "." ],
    "entities_indices" : [ [ 8, 9 ], [ 10, 11 ], [ 12, 13 ] ]
  }, {
    "sentence_tokens" : [ "BRAF-", "wild-type", "Nthy-ori", "3-1", "cells", "were", "used", "as", "a", "negative", "control", "and", "did", "not", "demonstrate", "appreciable", "apoptosis", "in", "any", "treatment", "group", "(", "Figure", "5A", ",", "5B", ")", "." ],
    "entities_indices" : [ [ 16, 17 ], [ 25, 26 ] ]
  }, {
    "sentence_tokens" : [ "Evidence", "for", "anti-tumor", "effects", "of", "metformin", "alone", "has", "been", "accruing", "for", "several", "types", "of", "cancer", ",", "although", "exact", "mechanisms", "are", "yet", "to", "be", "determined", "and", "most", "studies", "involve", "diabetic", "patients", "." ],
    "entities_indices" : [ [ 5, 6 ] ]
  }, {
    "sentence_tokens" : [ "Complete", "media", "was", "replaced", "with", "5", "%", "charcoal", "dextran", "treated", "FBS", "containing", "media", "+/-", "2", "mM", "metformin", "and", "flasks", "were", "incubated", "for", "24", "hours", "before", "+/-", "10", "mu", "M", "vemurafenib", "treatment", "for", "an", "additional", "24", "hours", "." ],
    "entities_indices" : [ [ 7, 8 ], [ 8, 9 ], [ 10, 11 ], [ 16, 17 ], [ 29, 30 ] ]
  }, {
    "sentence_tokens" : [ "In", "this", "study", ",", "we", "investigated", "the", "combination", "of", "BRAFV600E", "inhibition", "and", "mTOR", "inhibition", "in", "thyroid", "cancer", "cells", "." ],
    "entities_indices" : [ [ 12, 13 ] ]
  }, {
    "sentence_tokens" : [ "APO-BrdU", "tunel", "assay", "." ],
    "entities_indices" : [ [ 0, 1 ] ]
  }, {
    "sentence_tokens" : [ "Similar", "concentrations", "(", "1-20", "mM", ")", "were", "required", "for", "AMPK", "activation", "in", "a", "prior", "study", "investigating", "metformin", "and", "vemurafenib", "in", "melanoma", "cells", "." ],
    "entities_indices" : [ [ 9, 10 ], [ 16, 17 ], [ 18, 19 ], [ 20, 21 ] ]
  }, {
    "sentence_tokens" : [ "Other", "targeted", "agents", "currently", "in", "clinical", "trials", "for", "thyroid", "cancer", "include", "BRAFV600E", "inhibitors", "such", "as", "vemurafenib.The", "BRAFV600E", "mutation", "is", "found", "in", "approximately", "one-half", "of", "papillary", "thyroid", "cancers", "and", "one-fourth", "of", "anaplastic", "thyroid", "cancers", "and", "is", "associated", "with", "poor", "prognosis", "[", "4-6", "]", "." ],
    "entities_indices" : [ [ 15, 16, 17, 18 ], [ 24, 25, 26, 27 ], [ 30, 31, 32, 33 ] ]
  }, {
    "sentence_tokens" : [ "Changes", "in", "expression", "of", "signaling", "molecules", "such", "as", "decreased", "mTOR", "expression", "in", "BCPAP", "and", "enhanced", "inhibition", "of", "phospho-MAPK", "in", "resistant", "BCPAP", "and", "8505c", "were", "observed", "." ],
    "entities_indices" : [ [ 9, 10 ], [ 17, 18 ] ]
  }, {
    "sentence_tokens" : [ "Percentage", "of", "apoptotic", "cells", "changed", "very", "little", "between", "untreated", "(", "2.5", "%", ")", "and", "vemurafenib", "treated", "(", "1.6", "%", ")", "samples", "of", "8505c", "anaplastic", "thyroid", "cells", "." ],
    "entities_indices" : [ [ 14, 15 ], [ 24, 25 ] ]
  }, {
    "sentence_tokens" : [ "If", "changes", "in", "metabolism", "contribute", "to", "resistance", ",", "co-treatment", "with", "agents", "that", "alter", "cellular", "energy", "balance", "may", "hinder", "development", "of", "resistance", "or", "be", "effective", "against", "resistant", "tumors", ",", "as", "suggested", "by", "our", "results", "in", "thyroid", "cancer", "cells", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 26, 27 ] ]
  }, {
    "sentence_tokens" : [ "As", "expected", ",", "BRAFV600E", "positive", "BCPAP", "papillary", "thyroid", "cancer", "cells", "were", "susceptible", "to", "vemurafenib", "in", "terms", "of", "viability", ",", "which", "was", "decreased", "to", "50", "%", "that", "of", "untreated", "(", "Figure", "1B", ")", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 6, 7, 8, 9 ] ]
  }, {
    "sentence_tokens" : [ "We", "analyzed", "expression", "of", "MAPK", "and", "mTOR", "in", "response", "to", "metformin", "and", "combination", "treatment", "to", "determine", "whether", "signaling", "effects", "could", "play", "a", "role", "in", "mediating", "anti-proliferative", "effects", "." ],
    "entities_indices" : [ [ 4, 5 ], [ 6, 7 ], [ 8, 9, 10, 11 ] ]
  }, {
    "sentence_tokens" : [ "HER2", "and", "HER3", "dimers", "were", "found", "to", "be", "increased", "in", "thyroid", "cells", "after", "vemurafenib", "treatment", "and", "are", "capable", "of", "activating", "several", "intracellular", "signaling", "pathways", "[", "15", "]", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 2, 3 ], [ 10, 11 ], [ 13, 14 ] ]
  }, {
    "sentence_tokens" : [ "Cells", "were", "then", "treated", "with", "+/-", "10", "mu", "M", "vemurafenib", "for", "36", "hours", "before", "viable", "cells", "were", "counted", "as", "cells", "unable", "to", "take", "up", "0.4", "%", "trypan", "blue", "solution", "(", "Sigma", ")", "." ],
    "entities_indices" : [ [ 9, 10 ], [ 26, 27, 28 ] ]
  }, {
    "sentence_tokens" : [ "Brose", "et", "al.", "presented", "results", "of", "an", "ongoing", "phase", "II", "clinical", "study", "for", "vemurafenib", "in", "patients", "with", "metastatic", "or", "unresectable", "BRAFV600E", "positive", "papillary", "thyroid", "cancer", "at", "the", "2013", "ECCO/ESMO/ESTRO", "Annual", "Meeting", "." ],
    "entities_indices" : [ [ 13, 14 ], [ 22, 23, 24, 25 ] ]
  }, {
    "sentence_tokens" : [ "Proteins", "on", "gels", "were", "transferred", "to", "Immobilon-P", "membranes", "for", "2", "hours", "at", "220", "mA", "in", "a", "transfer", "chamber", "." ],
    "entities_indices" : [ [ 13, 14 ] ]
  }, {
    "sentence_tokens" : [ "DAPI", "fluorescence", "was", "excited", "with", "the", "UV", "laser", "(", "355", "nm", ")", ",", "AlexaFluor", "488", ",", "with", "the", "argon", "ion", "(", "488", "nm", ")", "laser", ",", "as", "described", "earlier", "[", "49", "]", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 18, 19 ] ]
  }, {
    "sentence_tokens" : [ "More", "recently", ",", "a", "second", "kinase", "inhibitor", "lenvatinib", "was", "approved", "." ],
    "entities_indices" : [ [ 7, 8 ] ]
  }, {
    "sentence_tokens" : [ "Potent", "inhibitors", "of", "BRAFV600E", ",", "such", "as", "vemurafenib", ",", "show", "great", "promise", "for", "treatment", "of", "BRAFV600E", "positive", "thyroid", "cancer", "." ],
    "entities_indices" : [ [ 7, 8 ], [ 15, 16 ] ]
  }, {
    "sentence_tokens" : [ "We", "used", "an", "in", "vitro", "model", "to", "examine", "combination", "treatment", "with", "vemurafenib", "and", "mammalian", "target", "of", "rapamycin", "(", "mTOR", ")", "inhibitors", ",", "metformin", "and", "rapamycin", "." ],
    "entities_indices" : [ [ 11, 12 ], [ 13, 14, 15, 16, 17 ], [ 18, 19 ], [ 22, 23 ], [ 24, 25 ] ]
  }, {
    "sentence_tokens" : [ "In", "the", "vemurafenib", "treated", "group", ",", "decreased", "viability", "may", "indicate", "slower", "growth", "rate", "or", "the", "presence", "of", "disrupted", "cells", "without", "DNA", "strand", "breaks", "." ],
    "entities_indices" : [ [ 2, 3 ] ]
  }, {
    "sentence_tokens" : [ "Resistant", "BCPAP", "cells", "were", "not", "susceptible", "to", "metformin", "alone", ",", "indicating", "that", "a", "rewiring", "process", "of", "acquired", "resistance", "may", "have", "enabled", "a", "distinct", "survival", "pathway", "inhibited", "only", "with", "combination", "therapy", "." ],
    "entities_indices" : [ [ 7, 8 ] ]
  }, {
    "sentence_tokens" : [ "Cell", "suspensions", "from", "the", "APO-BrdU", "TUNEL", "assay", "were", "prepared", "for", "viewing", "on", "glass", "slides", "by", "cytospin", "." ],
    "entities_indices" : [ [ 15, 16 ] ]
  }, {
    "sentence_tokens" : [ "Rapamycin-vemurafenib", "combination", "treatment", "increases", "frequency", "of", "apoptosis", "in", "BCPAP", "cells", "." ],
    "entities_indices" : [ [ 6, 7 ] ]
  }, {
    "sentence_tokens" : [ "It", "is", "only", "at", "the", "late", "stage", "of", "apoptosis", "that", "integrity", "of", "plasma", "membrane", "is", "not", "preserved", "." ],
    "entities_indices" : [ [ 8, 9 ] ]
  }, {
    "sentence_tokens" : [ "Thus", ",", "we", "investigated", "effects", "of", "combination", "metformin", "and", "vemurafenib", "in", "thyroid", "cancer", "cells", ",", "hypothesizing", "enhanced", "cytotoxic", "effects.We", "also", "investigated", "the", "potential", "combination", "of", "vemurafenib", "and", "rapamycin", "in", "thyroid", "cancer", "cells", "." ],
    "entities_indices" : [ [ 7, 8 ], [ 9, 10 ], [ 25, 26 ], [ 27, 28 ] ]
  }, {
    "sentence_tokens" : [ "Only", "30", "%", "of", "patients", "with", "radioiodine-refractory", "differentiated", "thyroid", "cancer", "and", "pulmonary", "metastasis", "survive", "5", "years", "after", "diagnosis", "[", "1", "]", "." ],
    "entities_indices" : [ [ 12, 13 ] ]
  }, {
    "sentence_tokens" : [ "The", "resistant", "BCPAP", "cells", "were", "maintained", "in", "culture", "with", "intermittent", "treatments", "of", "16", "mu", "M", "vemurafenib", "." ],
    "entities_indices" : [ [ 15, 16 ] ]
  }, {
    "sentence_tokens" : [ "Metformin-vemurafenib", "combination", "treatment", "increases", "frequency", "of", "apoptosis", "in", "BCPAP", "and", "8505c", "cells", "." ],
    "entities_indices" : [ [ 6, 7 ] ]
  }, {
    "sentence_tokens" : [ "Nthy-ori", "3-1", "braf-wild-type", "thyroid", "cells", "demonstrated", "no", "significant", "changes", "in", "cell", "viability", "in", "response", "to", "any", "of", "the", "treatments", "compared", "to", "untreated", "(", "Figure", "1A", ")", "." ],
    "entities_indices" : [ [ 3, 4 ], [ 10, 11, 12 ] ]
  }, {
    "sentence_tokens" : [ "BrdU", "incorporated", "into", "DNA", "at", "the", "site", "of", "breaks", "was", "detected", "by", "anti-BrdU", "antibody", "labeled", "with", "Alexa", "Fluor", "488", "dye", "." ],
    "entities_indices" : [ [ 0, 1 ], [ 16, 17, 18, 19 ] ]
  }, {
    "sentence_tokens" : [ "Interestingly", ",", "the", "combination", "of", "rapamycin", "and", "vemurafenib", "decreased", "viability", "significantly", "in", "BCPAP", "papillary", "thyroid", "cancer", "cells", ",", "even", "compared", "to", "the", "vemurafenib", "treated", "sample", "." ],
    "entities_indices" : [ [ 5, 6 ], [ 7, 8 ], [ 13, 14, 15, 16 ], [ 22, 23 ] ]
  }, {
    "sentence_tokens" : [ "Recent", "research", "in", "both", "melanoma", "and", "colorectal", "cancer", "revealed", "that", "combination", "therapy", "including", "BRAFV600E", "inhibition", "may", "provide", "greater", "benefits", "." ],
    "entities_indices" : [ [ 4, 5 ] ]
  }, {
    "sentence_tokens" : [ "We", "observed", "a", "general", "pattern", "of", "decreased", "viability", "corresponding", "to", "increased", "apoptosis", "." ],
    "entities_indices" : [ [ 11, 12 ] ]
  }, {
    "sentence_tokens" : [ "Co-treatment", "with", "metformin", "and", "vemurafenib", "led", "to", "enhanced", "inhibition", "of", "phospho-MAPK", "expression", "in", "resistant", "BCPAP", "and", "8505c", "cells", "compared", "to", "vemurafenib", "alone", "(", "Figure", "3", ")", "." ],
    "entities_indices" : [ [ 2, 3 ], [ 4, 5 ], [ 10, 11 ], [ 20, 21 ] ]
  } ],
  "emptySentences" : [ {
    "sentence_tokens" : [ "mTOR", "inhibitors", "sensitize", "thyroid", "cancer", "cells", "to", "cytotoxic", "effect", "of", "vemurafenib", "." ]
  }, {
    "sentence_tokens" : [ "Treatment", "options", "for", "advanced", "metastatic", "thyroid", "cancer", "patients", "are", "limited", "." ]
  }, {
    "sentence_tokens" : [ "Vemurafenib", ",", "a", "BRAFV600E", "inhibitor", ",", "has", "shown", "promise", "in", "clinical", "trials", "although", "cellular", "resistance", "occurs", "." ]
  }, {
    "sentence_tokens" : [ "Combination", "therapy", "that", "includes", "BRAFV600E", "inhibition", "and", "avoids", "resistance", "is", "a", "clinical", "need", "." ]
  }, {
    "sentence_tokens" : [ "We", "used", "an", "in", "vitro", "model", "to", "examine", "combination", "treatment", "with", "vemurafenib", "and", "mammalian", "target", "of", "rapamycin", "(", "mTOR", ")", "inhibitors", ",", "metformin", "and", "rapamycin", "." ]
  }, {
    "sentence_tokens" : [ "Cellular", "viability", "and", "apoptosis", "were", "analyzed", "in", "thyroid", "cell", "lines", "by", "trypan", "blue", "exclusion", "and", "TUNEL", "assays", "." ]
  }, {
    "sentence_tokens" : [ "This", "combination", "was", "also", "found", "to", "be", "active", "in", "vemurafenib", "resistant", "BCPAP", "cells", "." ]
  }, {
    "sentence_tokens" : [ "Changes", "in", "expression", "of", "signaling", "molecules", "such", "as", "decreased", "mTOR", "expression", "in", "BCPAP", "and", "enhanced", "inhibition", "of", "phospho-MAPK", "in", "resistant", "BCPAP", "and", "8505c", "were", "observed", "." ]
  }, {
    "sentence_tokens" : [ "The", "second", "combination", "of", "vemurafenib", "and", "rapamycin", "amplified", "cell", "death", "in", "BCPAP", "cells", "." ]
  }, {
    "sentence_tokens" : [ "We", "conclude", "that", "combination", "of", "BRAFV600E", "and", "mTOR", "inhibition", "forms", "the", "basis", "of", "a", "treatment", "regimen", "that", "should", "be", "further", "investigated", "in", "in", "vivo", "model", "systems", "." ]
  }, {
    "sentence_tokens" : [ "Metformin", "or", "rapamycin", "adjuvant", "treatment", "may", "provide", "clinical", "benefits", "with", "minimal", "side", "effects", "to", "BRAFV600E", "positive", "advanced", "thyroid", "cancer", "patients", "treated", "with", "vemurafenib", "." ]
  }, {
    "sentence_tokens" : [ "INTRODUCTION", "." ]
  }, {
    "sentence_tokens" : [ "Most", "cases", "of", "thyroid", "cancer", "are", "treated", "successfully", "with", "surgical", "resection", ",", "radioiodine", ",", "and", "thyroid", "hormone", "therapy", "." ]
  }, {
    "sentence_tokens" : [ "However", ",", "there", "are", "few", "treatment", "options", "available", "for", "patients", "with", "advanced", "disease", "including", "radioiodine", "resistant", "and", "metastatic", "differentiated", "thyroid", "cancer", "and", "anaplastic", "thyroid", "cancer", "." ]
  }, {
    "sentence_tokens" : [ "Only", "30", "%", "of", "patients", "with", "radioiodine-refractory", "differentiated", "thyroid", "cancer", "and", "pulmonary", "metastasis", "survive", "5", "years", "after", "diagnosis", "[", "1", "]", "." ]
  }, {
    "sentence_tokens" : [ "In", "addition", ",", "anaplastic", "thyroid", "cancer", "patients", "face", "an", "average", "life", "expectancy", "of", "less", "than", "one", "year", "." ]
  }, {
    "sentence_tokens" : [ "Recent", "progress", "in", "the", "treatment", "of", "advanced", "thyroid", "cancer", "patients", "includes", "targeted", "therapy", "." ]
  }, {
    "sentence_tokens" : [ "In", "2013", ",", "the", "kinase", "inhibitor", "sorafenib", "became", "the", "first", "drug", "since", "doxorubicin", "to", "be", "FDA", "approved", "in", "the", "past", "40", "years", "for", "treatment", "of", "radioiodine", "resistant", "metastatic", "well", "differentiated", "thyroid", "cancer", "[", "1", "]", "." ]
  }, {
    "sentence_tokens" : [ "More", "recently", ",", "a", "second", "kinase", "inhibitor", "lenvatinib", "was", "approved", "." ]
  }, {
    "sentence_tokens" : [ "Both", "drugs", "improved", "progression-free", "survival", "compared", "to", "placebo", "in", "phase", "3", "trials", "[", "2", ",", "3", "]", "." ]
  }, {
    "sentence_tokens" : [ "Other", "targeted", "agents", "currently", "in", "clinical", "trials", "for", "thyroid", "cancer", "include", "BRAFV600E", "inhibitors", "such", "as", "vemurafenib.The", "BRAFV600E", "mutation", "is", "found", "in", "approximately", "one-half", "of", "papillary", "thyroid", "cancers", "and", "one-fourth", "of", "anaplastic", "thyroid", "cancers", "and", "is", "associated", "with", "poor", "prognosis", "[", "4-6", "]", "." ]
  }, {
    "sentence_tokens" : [ "The", "rationale", "behind", "targeting", "BRAFV600E", "kinase", "is", "that", "this", "protein", "is", "specific", "to", "cancer", "cells", "and", "drives", "the", "growth", "promoting", "MAPK", "pathway", "." ]
  }, {
    "sentence_tokens" : [ "Thyroid", "cancer", "cells", "become", "dependent", "on", "BRAFV600E", "constitutive", "activation", "for", "growth", ",", "survival", ",", "and", "tumor", "progression", "." ]
  }, {
    "sentence_tokens" : [ "Short-term", "treatment", "with", "BRAFV600E", "inhibitors", "has", "drastic", "anti-proliferative", "effects", "on", "mutated", "thyroid", "cancer", "cells", "including", "induction", "of", "apoptosis", "[", "8-10", "]", "." ]
  }, {
    "sentence_tokens" : [ "The", "drug", "vemurafenib", "has", "also", "recently", "proved", "to", "be", "useful", "in", "treating", "advanced", "thyroid", "cancer", "patients", "in", "clinical", "trials.In", "an", "earlier", "study", ",", "one", "patient", "with", "metastatic", "thyroid", "cancer", "experienced", "a", "partial", "response", "including", "reduced", "pulmonary", "lesions", "after", "treatment", "with", "vemurafenib", ",", "and", "the", "two", "other", "patients", "had", "stable", "disease", "[", "11", "]", "." ]
  }, {
    "sentence_tokens" : [ "Additionally", ",", "two", "individual", "case", "reports", "documented", "tumor", "regression", "in", "response", "to", "vemurafenib", "in", "a", "patient", "with", "anaplastic", "thyroid", "cancer", "and", "a", "patient", "with", "advanced", "papillary", "thyroid", "cancer", "[", "12", ",", "13", "]", "." ]
  }, {
    "sentence_tokens" : [ "Brose", "et", "al.", "presented", "results", "of", "an", "ongoing", "phase", "II", "clinical", "study", "for", "vemurafenib", "in", "patients", "with", "metastatic", "or", "unresectable", "BRAFV600E", "positive", "papillary", "thyroid", "cancer", "at", "the", "2013", "ECCO/ESMO/ESTRO", "Annual", "Meeting", "." ]
  }, {
    "sentence_tokens" : [ "These", "results", "also", "demonstrate", "an", "anti-tumor", "effect", "thus", "far", ",", "especially", "in", "those", "patients", "who", "have", "not", "been", "treated", "with", "other", "tyrosine", "kinase", "inhibitors", "." ]
  }, {
    "sentence_tokens" : [ "Off-label", "use", "of", "vemurafenib", "for", "17", "patients", "with", "BRAFV600E", "positive", "advanced", "papillary", "thyroid", "cancer", "was", "reviewed", "retrospectively", "and", "found", "to", "be", "effective", "and", "well", "tolerated", "[", "14", "]", "." ]
  }, {
    "sentence_tokens" : [ "Combination", "therapy", "including", "BRAFV600E", "inhibitors", "is", "a", "promising", "option", "to", "delay", "or", "prevent", "resistance", "and", "further", "improve", "therapy", "for", "BRAFV600E", "positive", "thyroid", "cancer", "patients", "." ]
  }, {
    "sentence_tokens" : [ "Researchers", "are", "now", "investigating", "combinations", "of", "targeted", "inhibitors", ",", "including", "dabrafenib", "(", "BRAFV600E", "inhibitor", ")", "and", "lapatinib", "(", "HER2", "and", "neu", "and", "EGFR", "inhibitor", ")", "in", "refractory", "and", "inoperable", "BRAFV600E", "positive", "thyroid", "cancer", "." ]
  }, {
    "sentence_tokens" : [ "HER2", "and", "HER3", "dimers", "were", "found", "to", "be", "increased", "in", "thyroid", "cells", "after", "vemurafenib", "treatment", "and", "are", "capable", "of", "activating", "several", "intracellular", "signaling", "pathways", "[", "15", "]", "." ]
  }, {
    "sentence_tokens" : [ "It", "is", "likely", "that", "activation", "of", "multiple", "growth", "promoting", "signaling", "pathways", "including", "MAPK", "and", "PI3K", "and", "Akt", "contributes", "to", "development", "of", "vemurafenib", "resistance", "." ]
  }, {
    "sentence_tokens" : [ "One", "study", "concluded", "that", "BRAF", "inhibition", "resistance", "pathways", "converge", "to", "regulate", "translation", "of", "mRNAs", "through", "formation", "of", "the", "eIF4F", "initiation", "complex", "[", "16", "]", "." ]
  }, {
    "sentence_tokens" : [ "Since", "mammalian", "target", "of", "rapamycin", "(", "mTOR", ")", "is", "a", "major", "regulator", "of", "translation", "via", "eIF4F", "initiation", "complex", "formation", "and", "receives", "input", "from", "cell", "signaling", "pathways", ",", "it", "is", "also", "a", "rational", "target", "for", "combination", "therapy.In", "this", "study", "we", "investigated", "the", "combination", "of", "vemurafenib", "and", "mTOR", "inhibitors", ",", "metformin", "and", "rapamycin", ",", "which", "has", "not", "yet", "been", "explored", "in", "thyroid", "cancer", "." ]
  }, {
    "sentence_tokens" : [ "Evidence", "for", "anti-tumor", "effects", "of", "metformin", "alone", "has", "been", "accruing", "for", "several", "types", "of", "cancer", ",", "although", "exact", "mechanisms", "are", "yet", "to", "be", "determined", "and", "most", "studies", "involve", "diabetic", "patients", "." ]
  }, {
    "sentence_tokens" : [ "One", "study", "found", "that", "treatment", "with", "metformin", "in", "diabetic", "patients", "with", "thyroid", "cancer", "resulted", "in", "smaller", "tumor", "size", "and", "greater", "chance", "of", "complete", "remission", "[", "17", "]", "." ]
  }, {
    "sentence_tokens" : [ "Studies", "in", "the", "laboratory", "have", "also", "confirmed", "growth-inhibitory", "effects", "of", "metformin", "on", "thyroid", "cancer", "cells", "[", "18", ",", "19", "]", "." ]
  }, {
    "sentence_tokens" : [ "These", "effects", "were", "attributed", "to", "activation", "of", "AMP", "kinase", "and", "inhibition", "of", "growth", "promoting", "Akt", "and", "mTOR", "[", "19", "]", "." ]
  }, {
    "sentence_tokens" : [ "Along", "with", "inhibition", "of", "mTOR", "signaling", ",", "there", "are", "several", "mechanisms", "proposed", "for", "anti-cancer", "effects", "of", "metformin", "including", "STAT3", "inhibition", "leading", "to", "induction", "of", "apoptosis", "and", "effects", "on", "cancer", "related", "miRNAs", "[", "20", "]", "." ]
  }, {
    "sentence_tokens" : [ "Thus", ",", "we", "investigated", "effects", "of", "combination", "metformin", "and", "vemurafenib", "in", "thyroid", "cancer", "cells", ",", "hypothesizing", "enhanced", "cytotoxic", "effects.We", "also", "investigated", "the", "potential", "combination", "of", "vemurafenib", "and", "rapamycin", "in", "thyroid", "cancer", "cells", "." ]
  }, {
    "sentence_tokens" : [ "Rapamycin", "is", "an", "immunosuppressant", "used", "to", "prevent", "organ", "transplant", "rejection", ",", "especially", "in", "kidney", "transplants", "." ]
  }, {
    "sentence_tokens" : [ "It", "has", "also", "been", "researched", "as", "an", "anti-cancer", "agent", "due", "to", "its", "anti-proliferative", "effects", "which", "are", "more", "potent", "than", "its", "immunosuppressive", "effects", "in", "terms", "of", "tumor", "growth", "[", "21", "]", "." ]
  }, {
    "sentence_tokens" : [ "Rapamycin", "forms", "a", "complex", "with", "cytosolic", "FK", "binding", "protein", "12", "(", "FKBP12", ")", "and", "this", "complex", "serves", "as", "a", "direct", "and", "specific", "inhibitor", "of", "mTOR", "[", "22-26", "]", "." ]
  }, {
    "sentence_tokens" : [ "One", "phase", "II", "trial", "evaluated", "the", "efficacy", "and", "safety", "of", "everolimus", ",", "a", "rapamycin", "derivative", ",", "in", "advanced", "thyroid", "cancers", "and", "determined", "that", "the", "drug", "had", "some", "clinical", "benefit", "although", "further", "study", "is", "needed", "[", "27", "]", "." ]
  }, {
    "sentence_tokens" : [ "Inhibition", "of", "mTOR", "signaling", "with", "rapamycin", "in", "combination", "with", "inhibition", "of", "the", "driver", "mutated", "kinase", "BRAFV600E", "with", "vemurafenib", "in", "thyroid", "cancer", "may", "result", "in", "more", "profound", "anti-proliferative", "effects", "." ]
  }, {
    "sentence_tokens" : [ "We", "hypothesized", "that", "the", "combination", "treatment", "of", "vemurafenib", "with", "rapamycin", ",", "similar", "as", "with", "metformin", ",", "may", "also", "lead", "to", "enhanced", "cytotoxic", "effects", "in", "thyroid", "cancer", "cell", "lines", "." ]
  }, {
    "sentence_tokens" : [ "RESULTS", "." ]
  }, {
    "sentence_tokens" : [ "We", "measured", "viability", "of", "several", "thyroid", "cell", "lines", "after", "treatment", "with", "vemurafenib", ",", "metformin", ",", "and", "the", "combination", "." ]
  }, {
    "sentence_tokens" : [ "As", "expected", ",", "BRAFV600E", "positive", "BCPAP", "papillary", "thyroid", "cancer", "cells", "were", "susceptible", "to", "vemurafenib", "in", "terms", "of", "viability", ",", "which", "was", "decreased", "to", "50", "%", "that", "of", "untreated", "(", "Figure", "1B", ")", "." ]
  }, {
    "sentence_tokens" : [ "In", "addition", ",", "treatment", "with", "metformin", "alone", "and", "with", "combination", "treatment", "of", "vemurafenib", "and", "metformin", "decreased", "frequency", "of", "viable", "BCPAP", "cells", "to", "approximately", "50", "%", "of", "untreated", "cells", "(", "Figure", "1B", ")", "." ]
  }, {
    "sentence_tokens" : [ "Although", "8505c", "anaplastic", "thyroid", "cancer", "cells", "were", "unaffected", "by", "treatment", "with", "vemurafenib", ",", "metformin", "alone", "decreased", "their", "viability", "significantly", "to", "75", "%", "that", "of", "untreated", "." ]
  }, {
    "sentence_tokens" : [ "The", "metformin-vemurafenib", "combination", "further", "reduced", "8505c", "frequency", "of", "live", "cells", "to", "50", "%", "of", "untreated", "cells", ",", "and", "the", "number", "of", "viable", "cells", "was", "significantly", "lower", "than", "viable", "cells", "counted", "after", "treatment", "with", "metformin", "alone", "(", "Figure", "1D", ")", "." ]
  }, {
    "sentence_tokens" : [ "Nthy-ori", "3-1", "braf-wild-type", "thyroid", "cells", "demonstrated", "no", "significant", "changes", "in", "cell", "viability", "in", "response", "to", "any", "of", "the", "treatments", "compared", "to", "untreated", "(", "Figure", "1A", ")", "." ]
  }, {
    "sentence_tokens" : [ "Metformin-vemurafenib", "combination", "treatment", "significantly", "decreases", "viability", "in", "vemurafenib", "resistant", "BCPAP", "cells", "." ]
  }, {
    "sentence_tokens" : [ "Another", "cell", "line", "evaluated", "was", "resistant", "BCPAP", ",", "which", "was", "created", "in", "the", "laboratory", "by", "exposing", "BCPAP", "cells", "to", "increasing", "concentrations", "of", "vemurafenib", "." ]
  }, {
    "sentence_tokens" : [ "As", "expected", ",", "these", "cells", "were", "relatively", "resistant", "to", "treatment", "with", "vemurafenib", "alone", "compared", "to", "normal", "BCPAP", "(", "Figure", "1B", ",", "1C", ")", "." ]
  }, {
    "sentence_tokens" : [ "Interestingly", ",", "vemurafenib", "resistant", "BCPAP", "cells", "also", "appeared", "to", "be", "completely", "resistant", "to", "metformin", ",", "as", "there", "was", "no", "significant", "change", "in", "their", "viability", "in", "response", "to", "treatment", "with", "this", "drug", "as", "a", "single", "agent", "." ]
  }, {
    "sentence_tokens" : [ "However", ",", "the", "cell", "viability", "decreased", "significantly", ",", "to", "about", "50", "%", "of", "untreated", "cells", "after", "treatment", "with", "the", "combination", "of", "metformin", "and", "vemurafenib", "(", "Figure", "1C", ")", "." ]
  }, {
    "sentence_tokens" : [ "Metformin-vemurafenib", "combination", "treatment", "increases", "frequency", "of", "apoptosis", "in", "BCPAP", "and", "8505c", "cells", "." ]
  }, {
    "sentence_tokens" : [ "Apoptosis", ",", "or", "programmed", "cell", "death", ",", "was", "measured", "in", "each", "of", "the", "thyroid", "cell", "lines", "following", "treatment", "with", "vemurafenib", ",", "metformin", ",", "and", "the", "combination", "." ]
  }, {
    "sentence_tokens" : [ "Terminal", "Deoxynucleotide", "Transferase", "dUTP", "Nick", "End", "Labeling", "(", "TUNEL", ")", "was", "used", "to", "identify", "DNA", "strand", "breaks", "that", "are", "characteristic", "of", "apoptotic", "cells", "[", "28", "]", "." ]
  }, {
    "sentence_tokens" : [ "In", "Figure", "2", ",", "cells", "within", "the", "gated", "areas", "represent", "apoptotic", "cells", "with", "fragmented", "DNA", "(", "Figure", "2A", ")", "and", "this", "percentage", "is", "also", "represented", "graphically", "(", "Figure", "2B", ")", "." ]
  }, {
    "sentence_tokens" : [ "In", "the", "BCPAP", "papillary", "thyroid", "cancer", "cells", ",", "some", "degree", "of", "apoptosis", "occurred", "in", "the", "untreated", "group", "(", "11.3", "%", ")", "revealing", "the", "background", "level", "of", "cell", "death", "under", "experimental", "conditions", "." ]
  }, {
    "sentence_tokens" : [ "Between", "the", "vemurafenib", "treated", "sample", "and", "the", "metformin", "treated", "sample", "the", "number", "of", "apoptotic", "cells", "detected", "by", "this", "assay", "varied", "only", "slightly", ",", "at", "12.8", "%", "and", "9.33", "%", "of", "total", "cells", ",", "respectively", "." ]
  }, {
    "sentence_tokens" : [ "However", ",", "in", "the", "combination", "treatment", "group", ",", "BCPAP", "cells", "demonstrated", "increased", "frequency", "of", "apoptosis", "with", "31.0", "%", "of", "cells", "within", "the", "gated", "area", "(", "Figure", "2A", ",", "2B", ")", "." ]
  }, {
    "sentence_tokens" : [ "Percentage", "of", "apoptotic", "cells", "changed", "very", "little", "between", "untreated", "(", "2.5", "%", ")", "and", "vemurafenib", "treated", "(", "1.6", "%", ")", "samples", "of", "8505c", "anaplastic", "thyroid", "cells", "." ]
  }, {
    "sentence_tokens" : [ "Metformin", "treated", "8505c", "cells", "demonstrated", "a", "slight", "increase", "in", "apoptosis", "(", "4.8", "%", ")", "." ]
  }, {
    "sentence_tokens" : [ "As", "in", "the", "BCPAP", "cells", ",", "a", "greater", "than", "additive", "effect", "in", "terms", "of", "induction", "of", "apoptosis", "was", "observed", "in", "the", "8505c", "cells", "in", "response", "to", "combination", "treatment", "with", "metformin", "and", "vemurafenib", "." ]
  }, {
    "sentence_tokens" : [ "Drug", "combination", "treatment", "resulted", "in", "10.7", "%", "apoptotic", "cells", "(", "Figure", "2A", ",", "2B", ")", "." ]
  }, {
    "sentence_tokens" : [ "Effects", "of", "metformin", "on", "thyroid", "cancer", "cell", "signaling", "pathways", "are", "largely", "unknown", "." ]
  }, {
    "sentence_tokens" : [ "We", "analyzed", "expression", "of", "MAPK", "and", "mTOR", "in", "response", "to", "metformin", "and", "combination", "treatment", "to", "determine", "whether", "signaling", "effects", "could", "play", "a", "role", "in", "mediating", "anti-proliferative", "effects", "." ]
  }, {
    "sentence_tokens" : [ "Co-treatment", "with", "metformin", "and", "vemurafenib", "led", "to", "enhanced", "inhibition", "of", "phospho-MAPK", "expression", "in", "resistant", "BCPAP", "and", "8505c", "cells", "compared", "to", "vemurafenib", "alone", "(", "Figure", "3", ")", "." ]
  }, {
    "sentence_tokens" : [ "This", "effect", "was", "not", "observed", "in", "normal", "BCPAP", "." ]
  }, {
    "sentence_tokens" : [ "Effects", "on", "mTOR", "also", "varied", "among", "thyroid", "cancer", "cell", "lines", ",", "as", "total", "mTOR", "expression", "decreased", "in", "response", "to", "metformin", "in", "BCPAP", "and", "increased", "in", "8505c", "anaplastic", "cells", "(", "Figure", "3", ")", "." ]
  }, {
    "sentence_tokens" : [ "Rapamycin-vemurafenib", "combination", "treatment", "significantly", "decreases", "viability", "compared", "to", "vemurafenib", "alone", "in", "BCPAP", "cells", "." ]
  }, {
    "sentence_tokens" : [ "We", "investigated", "a", "second", "possible", "combination", "therapy", "of", "rapamycin", "and", "vemurafenib", "in", "thyroid", "cells", "." ]
  }, {
    "sentence_tokens" : [ "Rapamycin", "serves", "as", "a", "direct", "specific", "inhibitor", "of", "mTOR", "." ]
  }, {
    "sentence_tokens" : [ "In", "a", "series", "of", "viability", "assays", ",", "rapamycin", "treatment", "alone", "had", "no", "significant", "effect", "on", "cell", "viability", "in", "all", "thyroid", "cell", "lines", "analyzed", "(", "Figure", "4", ")", "." ]
  }, {
    "sentence_tokens" : [ "Interestingly", ",", "the", "combination", "of", "rapamycin", "and", "vemurafenib", "decreased", "viability", "significantly", "in", "BCPAP", "papillary", "thyroid", "cancer", "cells", ",", "even", "compared", "to", "the", "vemurafenib", "treated", "sample", "." ]
  }, {
    "sentence_tokens" : [ "Combination", "treatment", "resulted", "in", "a", "profound", "viability", "decrease", "to", "only", "25", "%", "that", "of", "the", "untreated", "sample", "(", "Figure", "4B", ")", "." ]
  }, {
    "sentence_tokens" : [ "In", "8505c", ",", "the", "difference", "in", "viability", "between", "vemurafenib", "treated", "and", "combination", "treated", "samples", "was", "not", "significant", "(", "Figure", "4D", ")", "." ]
  }, {
    "sentence_tokens" : [ "The", "resistant", "BCPAP", "and", "Nthy-ori", "3-1", "cells", "were", "not", "susceptible", "to", "rapamycin", "or", "the", "combination", "treatment", "in", "terms", "of", "viability", "(", "Figure", "4A", ",", "4C", ")", "." ]
  }, {
    "sentence_tokens" : [ "Rapamycin-vemurafenib", "combination", "treatment", "increases", "frequency", "of", "apoptosis", "in", "BCPAP", "cells", "." ]
  }, {
    "sentence_tokens" : [ "To", "further", "investigate", "cytotoxic", "effects", "in", "BCPAP", "cells", "in", "response", "to", "rapamycin", "and", "vemurafenib", ",", "we", "conducted", "another", "TUNEL", "based", "assay", "to", "evaluate", "apoptosis", "." ]
  }, {
    "sentence_tokens" : [ "We", "found", "the", "percentage", "of", "apoptotic", "cells", "increased", "in", "both", "vemurafenib", "and", "combination", "treatment", "groups", "compared", "to", "untreated", "cultures", "(", "Figure", "5A", ",", "5B", ")", "." ]
  }, {
    "sentence_tokens" : [ "Concordant", "with", "results", "of", "viability", "assays", ",", "combination", "treatment", "caused", "a", "greatly", "enhanced", "frequency", "of", "apoptosis", "compared", "to", "vemurafenib", "treatment", "alone", "." ]
  }, {
    "sentence_tokens" : [ "Percentage", "of", "apoptotic", "cells", "increased", "from", "about", "40", "%", "with", "vemurafenib", "alone", "to", "70", "%", "with", "the", "combination", "of", "rapamycin", "and", "vemurafenib", "(", "Figure", "5B", ")", "." ]
  }, {
    "sentence_tokens" : [ "We", "also", "detected", "a", "large", "population", "of", "cells", "with", "high", "TUNEL", "staining", "in", "the", "combination", "group", "seen", "in", "Figure", "5A", ",", "indicating", "a", "relative", "abundance", "of", "exposed", "3", "'-hydroxyl", "ends", "of", "the", "DNA", "strand", "breaks", "compared", "to", "cells", "treated", "with", "vemurafenib", "alone", "." ]
  }, {
    "sentence_tokens" : [ "In", "the", "latter", "case", "apoptotic", "cells", "were", "identified", "as", "cells", "with", "fractional", "DNA", "content", "(", "\"", "sub-G1", "\"", "cells", ")", "." ]
  }, {
    "sentence_tokens" : [ "Microscopically", ",", "vemurafenib", "treated", "BCPAP", "cells", "show", "distinct", "signs", "of", "apoptosis", "including", "chromatin", "condensation", "and", "nuclear", "fragmentation", "." ]
  }, {
    "sentence_tokens" : [ "The", "drug", "combination", "treated", "cells", "visualized", "support", "the", "finding", "of", "increased", "TUNEL", "positive", "staining", "measured", "by", "flow", "cytometry", "(", "Figure", "5C", ")", "." ]
  }, {
    "sentence_tokens" : [ "In", "this", "assay", ",", "there", "were", "few", "apoptotic", "cells", "detected", "in", "the", "untreated", "and", "rapamycin", "treated", "BCPAP", "cells", "(", "Figure", "5A", ",", "5B", ")", "." ]
  }, {
    "sentence_tokens" : [ "BRAF-", "wild-type", "Nthy-ori", "3-1", "cells", "were", "used", "as", "a", "negative", "control", "and", "did", "not", "demonstrate", "appreciable", "apoptosis", "in", "any", "treatment", "group", "(", "Figure", "5A", ",", "5B", ")", "." ]
  }, {
    "sentence_tokens" : [ "DISCUSSION", "." ]
  }, {
    "sentence_tokens" : [ "The", "use", "of", "targeted", "molecular", "therapy", "will", "likely", "continue", "to", "expand", "as", "cancer", "treatments", "become", "personalized", "and", "additional", "clinically", "relevant", "targets", "are", "discovered", "." ]
  }, {
    "sentence_tokens" : [ "Potent", "inhibitors", "of", "BRAFV600E", ",", "such", "as", "vemurafenib", ",", "show", "great", "promise", "for", "treatment", "of", "BRAFV600E", "positive", "thyroid", "cancer", "." ]
  }, {
    "sentence_tokens" : [ "BRAFV600E", "mutation", "is", "also", "found", "in", "melanoma", "and", "colorectal", "cancer", "." ]
  }, {
    "sentence_tokens" : [ "In", "cases", "of", "BRAFV600E", "positive", "colorectal", "cancers", ",", "inhibition", "of", "BRAFV600E", "alone", "was", "ineffective", ",", "largely", "due", "to", "feedback", "activation", "of", "epidermal", "growth", "factor", "receptor", "(", "EGFR", ")", "[", "31-34", "]", "." ]
  }, {
    "sentence_tokens" : [ "Recent", "research", "in", "both", "melanoma", "and", "colorectal", "cancer", "revealed", "that", "combination", "therapy", "including", "BRAFV600E", "inhibition", "may", "provide", "greater", "benefits", "." ]
  }, {
    "sentence_tokens" : [ "Clinical", "studies", "thus", "far", "include", "targeting", "molecules", "that", "fall", "directly", "within", "the", "canonical", "MAPK", "pathway", ",", "such", "as", "MEK", "in", "melanoma", "[", "35", ",", "36", "]", "and", "molecules", "that", "are", "membrane", "receptors", "activated", "due", "to", "feedback", "mechanisms", ",", "such", "as", "EGFR", "in", "colorectal", "cancer", "[", "37", "]", "." ]
  }, {
    "sentence_tokens" : [ "Immune", "checkpoint", "inhibitors", "combined", "with", "targeted", "therapy", "are", "also", "being", "considered", "in", "melanoma", "[", "38", "]", "." ]
  }, {
    "sentence_tokens" : [ "In", "this", "study", ",", "we", "investigated", "the", "combination", "of", "BRAFV600E", "inhibition", "and", "mTOR", "inhibition", "in", "thyroid", "cancer", "cells", "." ]
  }, {
    "sentence_tokens" : [ "Actions", "of", "metformin", "in", "cancer", "cells", "may", "also", "include", "reducing", "expression", "of", "key", "enzymes", "involved", "in", "fatty", "acid", "synthesis", "as", "well", "as", "membrane", "tyrosine", "kinase", "receptors", "[", "42-44", "]", "." ]
  }, {
    "sentence_tokens" : [ "The", "combination", "of", "vemurafenib", "and", "metformin", "is", "an", "example", "of", "a", "strategy", "to", "combine", "therapies", "that", "target", "both", "the", "driver", "mutation", "BRAFV600E", "and", "more", "broadly", "inhibit", "critical", "cellular", "signaling", "pathways", "related", "to", "metabolism", "." ]
  }, {
    "sentence_tokens" : [ "It", "has", "been", "proposed", "that", "resistance", "to", "targeted", "therapy", "can", "be", "mediated", "by", "rewiring", "of", "cellular", "metabolism", "[", "45", "]", "." ]
  }, {
    "sentence_tokens" : [ "If", "changes", "in", "metabolism", "contribute", "to", "resistance", ",", "co-treatment", "with", "agents", "that", "alter", "cellular", "energy", "balance", "may", "hinder", "development", "of", "resistance", "or", "be", "effective", "against", "resistant", "tumors", ",", "as", "suggested", "by", "our", "results", "in", "thyroid", "cancer", "cells", "." ]
  }, {
    "sentence_tokens" : [ "Further", "elucidation", "of", "the", "link", "between", "driver", "mutations", ",", "resistance", "to", "targeted", "therapy", "and", "metabolism", "may", "build", "upon", "new", "avenues", "for", "cancer", "therapies.Combination", "therapy", "with", "metformin", "and", "vemurafenib", "proved", "to", "be", "effective", "at", "inhibiting", "all", "thyroid", "cancer", "cell", "lines", "analyzed", ",", "including", "BCPAP", ",", "resistant", "BCPAP", ",", "and", "8505c", "." ]
  }, {
    "sentence_tokens" : [ "Induction", "of", "apoptosis", "was", "greatest", "in", "BCPAP", "and", "also", "occurred", "in", "8505c", "." ]
  }, {
    "sentence_tokens" : [ "We", "observed", "a", "general", "pattern", "of", "decreased", "viability", "corresponding", "to", "increased", "apoptosis", "." ]
  }, {
    "sentence_tokens" : [ "However", ",", "the", "combination", "treatment", "increased", "BCPAP", "apoptosis", "compared", "to", "vemurafenib", "alone", "without", "a", "significant", "change", "in", "viability", "between", "the", "two", "groups", "." ]
  }, {
    "sentence_tokens" : [ "A", "likely", "explanation", "is", "that", "decreases", "in", "cell", "viability", "may", "indicate", "decreased", "growth", "rate", "in", "response", "to", "treatment", ",", "in", "addition", "to", "cell", "death", "." ]
  }, {
    "sentence_tokens" : [ "In", "BCPAP", ",", "the", "decrease", "in", "viability", "after", "combination", "treatment", "can", "be", "attributed", "largely", "to", "the", "percentage", "of", "apoptotic", "cells", "detected", "by", "TUNEL", "." ]
  }, {
    "sentence_tokens" : [ "In", "the", "vemurafenib", "treated", "group", ",", "decreased", "viability", "may", "indicate", "slower", "growth", "rate", "or", "the", "presence", "of", "disrupted", "cells", "without", "DNA", "strand", "breaks", "." ]
  }, {
    "sentence_tokens" : [ "In", "regard", "to", "resistant", "BCPAP", "cells", ",", "viability", "decreased", "significantly", "without", "a", "corresponding", "increase", "in", "apoptosis", "after", "combination", "treatment", "." ]
  }, {
    "sentence_tokens" : [ "Thus", ",", "resistant", "BCPAP", "cells", "were", "susceptible", "to", "growth-inhibitory", "effects", "of", "the", "combination", "treatment", ",", "although", "overt", "apoptosis", "was", "not", "detected", "at", "this", "time", "point.It", "should", "be", "noted", "that", "the", "apparent", "discordance", "between", "the", "viability", "and", "apoptosis", "assays", "may", "also", "stem", "from", "the", "different", "end-points", "being", "measuring", "by", "each", "." ]
  }, {
    "sentence_tokens" : [ "The", "viability", "(", "trypan", "blue", "exclusion", ")", "assay", "detects", "cells", "with", "impaired", "integrity", "of", "plasma", "membrane", "that", "leads", "to", "inability", "to", "exclude", "cationic", "dyes", "." ]
  }, {
    "sentence_tokens" : [ "The", "apoptotic", "(", "TUNEL", ")", "assay", "detects", "cells", "with", "fragmented", "DNA", ";", "in", "the", "case", "of", "early-", "or", "mid-", "stage", "of", "apoptosis", "such", "cells", "have", "well", "preserved", "plasma", "membrane", "and", "do", "exclude", "trypan", "blue", "[", "28", "]", "." ]
  }, {
    "sentence_tokens" : [ "It", "is", "only", "at", "the", "late", "stage", "of", "apoptosis", "that", "integrity", "of", "plasma", "membrane", "is", "not", "preserved", "." ]
  }, {
    "sentence_tokens" : [ "A", "large", "fraction", "of", "DNA", "in", "the", "latter", "cells", "is", "fragmented", "to", "such", "small", "sections", "that", "they", "are", "extracted", "and", "not", "retained", "by", "fixation", "." ]
  }, {
    "sentence_tokens" : [ "Having", "only", "fractional", "DNA", "content", ",", "such", "cells", "present", "on", "the", "DNA", "content", "histograms", "as", "a", "distinct", "\"", "sub-G1", "\"", "subpopulation", "that", "may", "be", "TUNEL", "negative", "[", "28", "]", "." ]
  }, {
    "sentence_tokens" : [ "Interestingly", ",", "both", "the", "resistant", "BCPAP", "cells", "and", "the", "inherently", "resistant", "anaplastic", "8505c", "cells", "demonstrated", "a", "profound", "inhibition", "of", "phospho-MAPK", "expression", "." ]
  }, {
    "sentence_tokens" : [ "This", "suggests", "a", "role", "for", "metformin", "in", "interfering", "with", "signal", "transduction", "when", "combined", "with", "BRAFV600E", "inhibition", "and", "may", "account", "for", "decreased", "growth", "in", "viability", "assays", "." ]
  }, {
    "sentence_tokens" : [ "Resistant", "BCPAP", "cells", "were", "not", "susceptible", "to", "metformin", "alone", ",", "indicating", "that", "a", "rewiring", "process", "of", "acquired", "resistance", "may", "have", "enabled", "a", "distinct", "survival", "pathway", "inhibited", "only", "with", "combination", "therapy", "." ]
  }, {
    "sentence_tokens" : [ "Anti-proliferative", "effects", "of", "metformin", "in", "BCPAP", "cells", "may", "be", "driven", "through", "diminishment", "of", "mTOR", "expression.The", "concentration", "of", "2", "mM", "metformin", "used", "in", "this", "study", "is", "relatively", "high", "compared", "to", "expected", "human", "plasma", "levels", "of", "around", "10-40", "mu", "M", "after", "receiving", "a", "standard", "therapeutic", "dose", "." ]
  }, {
    "sentence_tokens" : [ "Similar", "concentrations", "(", "1-20", "mM", ")", "were", "required", "for", "AMPK", "activation", "in", "a", "prior", "study", "investigating", "metformin", "and", "vemurafenib", "in", "melanoma", "cells", "." ]
  }, {
    "sentence_tokens" : [ "It", "was", "proposed", "that", "low", "expression", "levels", "of", "OCT1", "transporter", "in", "cultured", "cells", "may", "account", "for", "this", "difference", ",", "which", "may", "also", "be", "the", "case", "for", "our", "thyroid", "cancer", "cell", "lines", "[", "46", "]", "." ]
  }, {
    "sentence_tokens" : [ "Data", "highlights", "a", "connection", "of", "metformin", "to", "cell", "signaling", "pathways", "." ]
  }, {
    "sentence_tokens" : [ "Further", "research", "defining", "the", "wide", "ranging", "effects", "of", "metformin", "at", "different", "concentrations", "and", "within", "different", "cell", "types", "is", "needed.The", "prior", "investigation", "with", "melanoma", "found", "synergistic", "anti-proliferative", "effects", "of", "vemurafenib", "and", "metformin", "in", "the", "majority", "of", "BRAFV600E", "positive", "cell", "lines", ",", "although", "some", "antagonistic", "effects", "were", "also", "seen", "[", "46", "]", "." ]
  }, {
    "sentence_tokens" : [ "In", "another", "study", ",", "a", "similar", "biguanide", "drug", ",", "phenformin", ",", "demonstrated", "cooperative", "effects", "to", "inhibit", "proliferation", "when", "combined", "with", "BRAFV600E", "inhibition", "in", "melanoma", "cells", "and", "also", "delayed", "development", "of", "resistance", "[", "47", "]", "." ]
  }, {
    "sentence_tokens" : [ "Although", "limited", "to", "an", "in", "vitro", "system", ",", "our", "study", "provides", "evidence", "that", "combination", "of", "targeted", "BRAFV600E", "inhibition", "with", "broader", "inhibition", "provided", "by", "metformin", "causes", "greater", "than", "additive", "inhibition", "of", "thyroid", "cancer", "cell", "growth", "and", "induction", "of", "apoptosis", "." ]
  }, {
    "sentence_tokens" : [ "Further", "in", "vivo", "studies", "may", "lead", "to", "benefits", "for", "patients", "with", "advanced", "BRAFV600E", "positive", "thyroid", "cancer", "." ]
  }, {
    "sentence_tokens" : [ "Combination", "treatment", "with", "rapamycin", "and", "vemurafenib", "proved", "to", "be", "effective", "only", "in", "BCPAP", "papillary", "thyroid", "cancer", "cells", ",", "possibly", "due", "to", "rapamycin", "'s", "more", "targeted", "mechanism", "of", "action", "." ]
  }, {
    "sentence_tokens" : [ "Resistant", "BCPAP", "cells", "and", "anaplastic", "8505c", "cells", "are", "likely", "better", "adapted", "to", "thrive", "in", "the", "face", "of", "targeted", "inhibition", "due", "to", "the", "availability", "of", "alternative", "signaling", "pathways", "." ]
  }, {
    "sentence_tokens" : [ "It", "is", "noteworthy", "that", "the", "combination", "of", "rapamycin", "and", "vemurafenib", "resulted", "in", "very", "marked", "induction", "of", "apoptosis", "in", "BCPAP", ",", "accounting", "for", "the", "decrease", "in", "viability", "." ]
  }, {
    "sentence_tokens" : [ "Apoptotic", "cells", "made", "up", "70", "%", "of", "all", "detected", "BCPAP", "cells", "and", "there", "was", "a", "large", "population", "of", "cells", "intensely", "stained", "with", "TUNEL", ",", "indicative", "of", "intensive", "DNA", "fragmentation", "and", "advanced", "progression", "of", "apoptosis", "[", "28", "]", "." ]
  }, {
    "sentence_tokens" : [ "Exquisite", "sensitivity", "to", "combination", "treatment", "targeting", "BRAFV600E", "and", "a", "downstream", "integrative", "molecule", "such", "as", "mTOR", "may", "be", "seen", "in", "a", "defined", "population", "of", "cancer", "cells", ",", "as", "in", "the", "case", "of", "BCPAP", "cells.Sensitivity", "of", "differentiated", "papillary", "thyroid", "cancer", "cells", "to", "rapamycin", "and", "vemurafenib", "treatment", "could", "be", "exploited", "clinically", "by", "treating", "with", "combination", "therapy", "early", "on", "in", "a", "patient", "'s", "clinical", "course", ",", "before", "resistance", "to", "vemurafenib", "develops", "." ]
  }, {
    "sentence_tokens" : [ "Combinations", "of", "vemurafenib", "and", "mTOR", "inhibitors", "should", "be", "further", "studied", "on", "human", "cancer", "xenografts", "on", "immunodeficient", "mice", ",", "to", "evaluate", "in", "vivo", "effects", "and", "potential", "clinical", "benefits", "for", "treatment", "of", "advanced", "thyroid", "cancer", "patients", "." ]
  }, {
    "sentence_tokens" : [ "MATERIALS", "AND", "METHODS", "." ]
  }, {
    "sentence_tokens" : [ "Cells", "and", "cell", "culture", "." ]
  }, {
    "sentence_tokens" : [ "Thyroid", "cell", "lines", "used", "in", "this", "study", "include", "a", "normal", "transformed", "line", "(", "Nthy-ori", "3-1", ")", ",", "a", "papillary", "thyroid", "cancer", "cell", "line", "(", "BCPAP", ")", ",", "and", "an", "anaplastic", "thyroid", "cancer", "cell", "line", "(", "8505c", ")", "." ]
  }, {
    "sentence_tokens" : [ "Dr.", "Norman", "L.", "Eberhardt", "(", "Mayo", "Clinic", ",", "Rochester", ",", "MN", ")", "generously", "gifted", "the", "Nthy-ori", "3-1", "cell", "line", "." ]
  }, {
    "sentence_tokens" : [ "BCPAP", "and", "8505c", "cell", "lines", "were", "purchased", "from", "DSMZ", "in", "Braunschweig", ",", "Germany", "." ]
  }, {
    "sentence_tokens" : [ "All", "cell", "lines", "were", "cultured", "in", "Rosswell", "Park", "Memorial", "Institute", "(", "RPMI", ")", "-1640", "supplemented", "with", "10", "%", "fetal", "bovine", "serum", "(", "FBS", ")", ",", "penicillin", "10", ",", "000", "IU/mL", ",", "streptomycin", "10", ",", "000", "mu", "g/mL", ",", "and", "2", "mM", "L-glutamine", "." ]
  }, {
    "sentence_tokens" : [ "Resistant", "BCPAP", "cell", "line", "." ]
  }, {
    "sentence_tokens" : [ "In", "order", "to", "create", "vemurafenib", "resistant", "BCPAP", "cells", ",", "cells", "were", "treated", "for", "24", "hours", "with", "increasing", "concentrations", "of", "vemurafenib", "(", "Chemietek", ",", "Indianapolis", ",", "IN", ")", "up", "to", "16", "mu", "M", ",", "subcultured", "and", "allowed", "to", "grow", "to", "70", "%", "confluence", "before", "the", "next", "treatment", "." ]
  }, {
    "sentence_tokens" : [ "Cells", "were", "treated", "with", "vemurafenib", "concentrations", "of", "10", "mu", "M", ",", "12", "mu", "M", ",", "14", "mu", "M", ",", "and", "16", "mu", "M", "over", "a", "period", "of", "45", "days", "." ]
  }, {
    "sentence_tokens" : [ "The", "resistant", "BCPAP", "cells", "were", "maintained", "in", "culture", "with", "intermittent", "treatments", "of", "16", "mu", "M", "vemurafenib", "." ]
  }, {
    "sentence_tokens" : [ "Trypan", "blue", "exclusion", "assay", "." ]
  }, {
    "sentence_tokens" : [ "Cells", "were", "plated", "in", "six-well", "culture", "plates", "and", "allowed", "to", "adhere", "overnight", "." ]
  }, {
    "sentence_tokens" : [ "Each", "well", "contained", "200,000", "cells", "(", "8505c", ")", "or", "300,000", "cells", "(", "Nthy-ori", "3-1", ",", "BCPAP", ",", "resistant", "BCPAP", ")", "in", "2", "mL", "media", "at", "the", "start", "of", "the", "experiment", "." ]
  }, {
    "sentence_tokens" : [ "Complete", "media", "was", "replaced", "with", "phenol-red-free", "RPMI", "containing", "5", "%", "charcoal", "dextran", "treated", "FBS", "+/-", "2", "mM", "metformin", "and", "plates", "were", "incubated", "for", "24", "hours", "." ]
  }, {
    "sentence_tokens" : [ "Cells", "were", "then", "treated", "with", "+/-", "10", "mu", "M", "vemurafenib", "for", "36", "hours", "before", "viable", "cells", "were", "counted", "as", "cells", "unable", "to", "take", "up", "0.4", "%", "trypan", "blue", "solution", "(", "Sigma", ")", "." ]
  }, {
    "sentence_tokens" : [ "For", "the", "rapamycin", "experiment", ",", "the", "same", "protocol", "was", "followed", "except", "cells", "were", "treated", "for", "24", "hours", "with", "phenol-red-free", "RPMI", "containing", "5", "%", "charcoal", "dextran", "treated", "FBS", "for", "24", "hours", "and", "then", "this", "media", "was", "replaced", "with", "fresh", "media", "containing", "+/-", "10", "mu", "M", "vemurafenib", ",", "+/-", "1", "mu", "M", "rapamycin", "for", "36", "hours", "." ]
  }, {
    "sentence_tokens" : [ "Trypan", "blue", "exclusion", "assays", "were", "repeated", "at", "least", "once", "in", "triplicates", "." ]
  }, {
    "sentence_tokens" : [ "APO-BrdU", "tunel", "assay", "." ]
  }, {
    "sentence_tokens" : [ "Thyroid", "cells", "were", "plated", "in", "6-well", "plates", "at", "300,000", "cells", "per", "well", "(", "Nthy-ori", "3-1", ",", "BCPAP", ",", "and", "resistant", "BCPAP", ")", "or", "200,000", "cells", "per", "well", "(", "8505c", ")", "and", "allowed", "to", "adhere", "overnight", "." ]
  }, {
    "sentence_tokens" : [ "Complete", "media", "was", "replaced", "with", "5", "%", "charcoal", "dextran", "treated", "FBS", "+/-", "2", "mM", "metformin", "and", "plates", "were", "incubated", "for", "24", "hours", "." ]
  }, {
    "sentence_tokens" : [ "Cells", "were", "then", "treated", "with", "+/-", "10", "mu", "M", "vemurafenib", "for", "36", "hours", "." ]
  }, {
    "sentence_tokens" : [ "Cells", "were", "collected", "and", "fixed", "with", "1", "%", "paraformaldehyde", "in", "PBS", "for", "1", "hour", "on", "ice", "." ]
  }, {
    "sentence_tokens" : [ "Cells", "were", "washed", "with", "PBS", "twice", "and", "resuspended", "in", "70", "%", "ethanol", "." ]
  }, {
    "sentence_tokens" : [ "Cells", "in", "solution", "were", "subjected", "to", "the", "APO-BRDU", "protocol", "(", "Phoenix", "Flow", "Systems", ",", "Inc", ".,", "San", "Diego", ",", "CA", ")", "." ]
  }, {
    "sentence_tokens" : [ "BrdU", "incorporated", "into", "DNA", "at", "the", "site", "of", "breaks", "was", "detected", "by", "anti-BrdU", "antibody", "labeled", "with", "Alexa", "Fluor", "488", "dye", "." ]
  }, {
    "sentence_tokens" : [ "Total", "cellular", "DNA", "was", "stained", "with", "DAPI", "." ]
  }, {
    "sentence_tokens" : [ "While", "most", "apoptotic", "cells", "were", "TUNEL-(", "Alexa", "Fluor", "488", ")", "-", "positive", ",", "following", "some", "treatments", "they", "were", "also", "identified", "as", "the", "cells", "with", "fractional", "DNA", "content", "(", "\"", "sub-G1", "\"", "cells", ")", "[", "28", ",", "48", "]", "." ]
  }, {
    "sentence_tokens" : [ "For", "the", "rapamycin", "experiment", ",", "the", "same", "protocol", "was", "followed", "except", "cells", "were", "treated", "for", "24", "hours", "with", "phenol-red-free", "RPMI", "containing", "5", "%", "charcoal", "dextran", "treated", "FBS", "and", "then", "media", "was", "replaced", "with", "fresh", "media", "containing", "+/-", "10", "mu", "M", "vemurafenib", "and", "+/-", "1", "mu", "M", "rapamycin", "for", "36", "hours", "." ]
  }, {
    "sentence_tokens" : [ "Intensity", "of", "cellular", "fluorescence", "was", "measured", "using", "a", "MoFlo", "XDP", "(", "Beckman-Coulter", ",", "Brea", ",", "CA", ")", "high", "speed", "flow", "cytometer", "and", "sorter", "." ]
  }, {
    "sentence_tokens" : [ "DAPI", "fluorescence", "was", "excited", "with", "the", "UV", "laser", "(", "355", "nm", ")", ",", "AlexaFluor", "488", ",", "with", "the", "argon", "ion", "(", "488", "nm", ")", "laser", ",", "as", "described", "earlier", "[", "49", "]", "." ]
  }, {
    "sentence_tokens" : [ "Western", "blot", "." ]
  }, {
    "sentence_tokens" : [ "Thyroid", "cells", "were", "allowed", "to", "grow", "in", "T75", "flasks", "until", "70", "%", "confluence", "." ]
  }, {
    "sentence_tokens" : [ "Complete", "media", "was", "replaced", "with", "5", "%", "charcoal", "dextran", "treated", "FBS", "containing", "media", "+/-", "2", "mM", "metformin", "and", "flasks", "were", "incubated", "for", "24", "hours", "before", "+/-", "10", "mu", "M", "vemurafenib", "treatment", "for", "an", "additional", "24", "hours", "." ]
  }, {
    "sentence_tokens" : [ "After", "treatment", ",", "cells", "were", "collected", "by", "gentle", "scraping", "with", "cell", "scrapers", ",", "subjected", "to", "radioimmunoprecipitation", "assay", "buffer", "(", "50mM", "Tris-HCl", "[", "pH", "7.4", "]", ",", "150mM", "NaCl", ",", "0.2", "%", "sodium", "deoxycholate", ",", "0.1", "%", "sodium", "dodecyl", "sulfate", "(", "SDS", ")", ",", "0.5", "%", "NP40", ",", "and", "1", "mu", "M", "Pefabloc", ")", "and", "vortexed", "every", "5", "minutes", "for", "30", "minutes", "over", "ice", "." ]
  }, {
    "sentence_tokens" : [ "Lysates", "were", "centrifuged", "at", "14,000", "rpm", "for", "30", "minutes", "at", "4", "degrees", "C", "and", "each", "supernatant", "was", "collected", "." ]
  }, {
    "sentence_tokens" : [ "Volumes", "containing", "10", "mu", "g", "protein", "per", "sample", "were", "subjected", "to", "12", "%", "SDS-polyacrylamide", "gel", "electrophoresis", "as", "in", "our", "prior", "studies", "[", "50", ",", "51", "]", "." ]
  }, {
    "sentence_tokens" : [ "Proteins", "on", "gels", "were", "transferred", "to", "Immobilon-P", "membranes", "for", "2", "hours", "at", "220", "mA", "in", "a", "transfer", "chamber", "." ]
  }, {
    "sentence_tokens" : [ "Membranes", "were", "blocked", "with", "5", "%", "milk", "in", "TBST", "(", "10", "mM", "Tris-HCl", ",", "pH", "7.5", ",", "200", "mM", "NaCl", ",", "0.05", "%", "Tween-20", ")", "for", "1.5", "hours", "at", "room", "temperature", "and", "then", "incubated", "overnight", "in", "primary", "antibodies", "(", "Cell", "Signaling", ")", "at", "4", "degrees", "Celsius", "." ]
  }, {
    "sentence_tokens" : [ "Membranes", "were", "washed", "three", "times", "with", "TBST", "for", "5", "minutes", "per", "wash", "and", "incubated", "with", "secondary", "antibody", "for", "2", "hours", "at", "room", "temperature", "." ]
  }, {
    "sentence_tokens" : [ "After", "4", "TBST", "washes", "of", "10", "minutes", "each", ",", "membranes", "were", "developed", "by", "enhanced", "chemiluminescence", "(", "Thermo", "Scientific", ")", "and", "detected", "on", "x-ray", "film", "." ]
  }, {
    "sentence_tokens" : [ "Immunofluorescence", "." ]
  }, {
    "sentence_tokens" : [ "Cell", "suspensions", "from", "the", "APO-BrdU", "TUNEL", "assay", "were", "prepared", "for", "viewing", "on", "glass", "slides", "by", "cytospin", "." ]
  }, {
    "sentence_tokens" : [ "Slides", "were", "viewed", "and", "images", "were", "captured", "using", "Axiovision", "Rel", "4.8", "on", "the", "Axiovert", "200", "M", "microscope", "(", "Carl", "Zeiss", "MicroImaging", ",", "Inc", ".,", "Thornwood", ",", "NY", ")", "." ]
  } ]
}